hg_119497.1

Basic information about the TSS

---

TSS ID: hg_119497.1 Species: human Chr: chr11		Start: 45918792 End: 45918848 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000532681.5 Distance: 0 GeneID: 9409 HGNC/MGI_ID: HGNC:8857 UniProt_ID: E9PP98

Gene_name: peroxisomal biogenesis factor 16 Gene_symbol: PEX16 Gene_synonyms: Gene_source: HGNC:8857

TATA-Box annotation

---

Distance to TSS:	-697
Nearest PromoterID:	NM_057174
Entrez ID:	9409
Nearest Unigene:	Hs.100915
Nearest Refseq:	NM_004813
Nearest Ensembl:	ENSG00000121680
Gene Name:	peroxisomal biogenesis factor 16
Gene Alias:	PBD8A|PBD8B
Gene Description:	peroxisomal biogenesis factor 16
Gene Type:	protein-coding
CpG%:	0.06
GC%:	0.681592
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PEX16 p2@PEX16 p3@PEX16 p4@PEX16 p5@PEX16 p6@PEX16 p7@PEX16
Sample		p1@PEX16	p2@PEX16	p3@PEX16	p4@PEX16	p5@PEX16	p6@PEX16	p7@PEX16
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	9.16	3.31	1.17	2.53	1.56	4.09	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	10.12	5.87	2.43	3.24	4.05	3.44	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	9.84	5.02	2.70	1.74	4.05	2.51	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	6.65	4.16	1.46	2.91	3.12	2.91	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	9.45	2.25	1.80	2.25	3.37	2.92	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	12.60	2.91	1.94	1.36	2.13	2.52	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	17.43	5.23	2.61	2.61	3.27	2.18	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	11.14	5.09	3.39	2.66	2.42	3.63	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	12.18	5.98	2.56	1.71	4.06	4.27	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	41.73	11.59	6.38	4.06	5.80	5.80	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	36.38	10.11	4.45	6.06	5.66	6.87	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	38.62	6.91	4.88	3.66	5.29	5.69	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	7.58	5.16	1.45	0.97	1.45	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	8.12	4.51	1.05	0.45	0.45	1.05	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.88	3.51	0.66	0.66	1.10	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.05	3.77	0.00	0.25	0.50	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	7.86	3.93	0.44	0.44	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	10.55	5.48	2.53	0.84	0.84	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	6.40	4.27	2.13	1.07	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	10.23	4.66	0.90	0.75	0.60	0.30	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	9.62	3.47	0.80	1.20	1.07	0.53	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.18	4.66	1.55	0.86	0.52	0.35	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.92	2.84	0.39	1.29	1.29	0.26	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.22	3.15	0.73	1.94	1.46	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	7.22	4.13	1.55	0.26	0.26	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	7.28	2.85	0.63	1.90	1.27	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	7.14	2.75	1.65	0.55	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	10.84	5.89	2.36	0.47	0.24	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	7.27	4.20	1.94	1.13	0.16	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	6.70	4.34	1.45	0.54	0.90	0.54	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	6.49	5.65	0.84	1.26	0.63	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.60	6.06	0.98	1.37	0.20	0.00	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	8.65	4.64	1.27	1.27	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	7.92	5.11	0.99	1.81	0.33	0.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	6.92	3.55	1.68	0.93	0.93	0.37	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	8.62	5.17	0.19	1.15	0.00	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	6.54	4.29	0.61	0.61	1.02	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	8.66	5.64	1.81	0.60	0.20	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	6.21	4.59	2.16	0.54	0.27	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	6.96	4.56	0.48	0.72	1.20	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.47	4.23	1.41	0.47	0.00	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	7.76	6.15	1.02	1.02	1.32	0.29	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.12	6.54	1.05	0.00	1.05	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	5.59	4.90	0.87	0.87	1.40	0.17	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	5.02	3.01	1.00	0.80	1.81	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	4.89	6.28	1.86	0.93	0.70	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.48	5.76	2.40	1.44	1.20	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	7.45	2.98	0.89	1.49	0.89	1.19	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	4.07	4.31	1.91	0.96	1.44	0.24	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	5.46	3.24	1.82	0.20	0.81	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	6.56	4.10	1.43	0.00	0.61	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	7.12	7.56	1.11	1.33	1.56	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	6.39	4.26	1.06	0.71	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	6.30	4.31	1.66	0.33	0.99	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	10.91	5.03	1.68	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	10.56	3.67	0.92	0.46	0.92	1.38	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	5.19	3.57	1.62	0.00	1.94	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	3.53	5.14	1.28	0.32	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	4.71	4.09	1.26	1.89	1.89	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.23	6.35	1.41	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.17	5.05	1.12	4.49	1.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	4.78	3.18	0.80	0.80	0.80	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	6.80	2.38	1.02	1.70	1.02	0.68	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	6.17	3.90	0.97	0.97	1.62	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	6.74	5.68	0.71	0.71	1.06	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	7.90	0.00	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	2.44	4.88	0.98	0.49	2.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	3.47	3.47	0.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	2.35	4.22	0.47	0.47	1.41	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	4.97	3.97	0.33	1.32	1.99	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	3.40	4.33	0.93	0.62	1.24	0.00	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	2.75	2.75	0.92	0.31	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	4.28	6.34	1.27	0.32	0.95	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	2.25	4.49	1.28	0.16	1.12	0.00	0.32
Adipocyte - omental, donor1	11473-119C6	4.07	5.34	1.15	0.64	0.89	0.25	0.64
Adipocyte - omental, donor2	11474-119C7	3.74	7.47	0.75	2.24	1.49	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	3.35	3.35	1.00	0.33	2.01	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	2.55	3.83	1.91	0.64	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	5.50	2.20	1.10	2.20	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	8.13	7.23	0.00	0.00	1.35	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	9.04	8.86	1.22	0.17	1.74	0.35	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	3.91	6.26	0.98	0.78	1.17	0.00	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	3.35	3.86	0.26	0.51	0.00	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	2.23	4.74	1.39	0.56	0.28	0.56	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	1.18	4.11	1.18	0.59	0.59	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	3.46	7.80	1.37	0.24	1.05	0.16	0.80
Adipocyte differentiation, day08, donor2	13023-139D8	2.58	4.52	1.29	0.65	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	1.60	3.20	0.53	0.53	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	1.11	5.01	0.00	1.11	1.11	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	2.08	8.73	2.08	0.00	0.42	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	1.26	4.27	1.00	0.50	1.26	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	2.62	4.25	0.98	0.98	2.29	0.98	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	1.83	3.65	0.00	0.30	0.91	0.30	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	7.51	5.97	3.09	1.99	0.44	0.44	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	12.55	7.17	2.87	1.79	2.87	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	3.59	1.20	1.20	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	4.14	3.60	0.90	1.44	1.80	0.54	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	6.69	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	2.88	4.52	0.21	1.85	0.62	0.62	0.21
Anulus Pulposus Cell, donor1	11248-116E6	11.10	8.24	2.06	1.14	0.46	0.34	0.57
Anulus Pulposus Cell, donor2	11463-119B5	8.33	3.67	1.96	0.98	0.49	0.00	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	4.94	0.90	1.35	0.45	0.90	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	3.47	5.21	2.60	0.87	0.00	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	4.28	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	4.18	2.99	0.30	0.30	0.60	1.20	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	2.53	1.26	0.00	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.96	5.94	1.32	1.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	4.87	1.62	3.25	0.97	0.65	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	5.34	2.43	2.91	0.00	0.97	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.16	2.97	0.59	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.14	3.39	1.13	0.00	1.51	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.26	2.18	0.00	2.18	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	2.51	1.25	1.25	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	6.92	5.44	0.66	1.15	1.15	0.49	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	0.00	2.73	1.36	0.00	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.28	5.28	0.75	1.51	0.30	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	4.29	4.29	0.00	1.07	0.54	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	4.91	5.10	1.13	0.76	0.76	0.76	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	4.54	3.21	1.34	0.27	0.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	3.90	3.90	0.00	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	3.65	3.81	1.00	1.16	0.66	0.83	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	2.40	4.80	2.40	0.00	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	3.54	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	4.97	3.26	1.20	1.03	0.34	0.34	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	8.74	4.37	2.43	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	4.55	3.04	0.38	0.76	0.76	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	2.42	0.00	0.00	1.21	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	3.99	2.85	0.57	0.00	0.00	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	4.06	2.35	0.21	1.50	0.21	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.42	3.87	2.06	0.77	0.52	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	2.82	2.82	0.94	0.47	0.47	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	4.18	2.57	0.00	1.29	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.99	3.57	1.43	0.00	0.71	0.71	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	3.51	2.92	1.75	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	4.52	2.11	0.90	0.00	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	2.38	4.75	2.38	1.19	1.19	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	2.54	3.05	1.02	1.02	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	5.09	4.33	0.76	0.51	0.00	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.08	4.45	0.64	0.00	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	4.75	3.45	0.43	1.73	0.86	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	3.60	2.54	0.21	0.42	0.21	0.64	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.06	4.64	1.74	0.87	0.29	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	5.67	1.89	0.94	0.00	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	3.90	3.39	0.51	1.19	0.34	0.17	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	4.63	2.32	4.63	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	2.11	2.11	2.11	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	3.65	3.43	1.07	0.64	1.07	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.02	3.01	0.60	0.60	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.10	1.46	2.19	1.46	1.46	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.29	4.37	0.69	0.69	1.15	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	7.12	4.32	1.78	0.51	0.51	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	4.34	3.72	2.06	1.03	0.83	0.41	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.28	3.98	0.92	1.53	0.92	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	6.21	2.87	0.48	0.96	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	5.77	3.33	1.11	0.89	1.55	0.00	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	4.58	3.05	3.05	1.53	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	5.54	2.77	2.77	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	3.97	2.91	1.06	1.06	0.53	1.06	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.45	4.36	1.09	0.73	0.73	0.36	0.73
Astrocyte - cerebellum, donor1	11500-119F6	5.40	7.12	1.72	1.35	1.11	1.11	0.37
Astrocyte - cerebellum, donor2	11580-120F5	6.33	4.11	2.23	1.03	1.71	0.86	0.17
Astrocyte - cerebellum, donor3	11661-122F5	4.61	7.76	1.89	0.21	1.68	0.42	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	4.53	6.97	1.39	2.44	1.39	1.74	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	4.85	6.63	0.49	1.13	1.78	0.81	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	5.07	4.33	1.49	1.34	1.34	0.60	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	10.21	5.28	2.06	0.80	4.82	1.26	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	10.52	7.27	2.00	1.38	4.26	1.63	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	8.65	6.49	1.25	1.25	3.30	1.14	0.57
Basophils, donor1	12241-129G9	15.17	14.65	2.09	2.88	0.78	1.83	1.57
Basophils, donor2	12242-129H1	14.79	18.04	2.53	3.25	0.72	2.53	1.44
Basophils, donor3	12243-129H2	8.82	10.88	1.47	1.32	0.44	1.47	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	7.76	5.61	1.94	0.65	0.43	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	22.40	12.34	3.20	2.29	5.49	0.91	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	20.08	10.67	1.88	1.88	4.39	0.00	3.14
Bronchial Epithelial Cell, donor5	11457-119A8	16.22	7.49	1.87	1.87	3.74	0.42	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	19.34	11.98	3.45	1.61	3.91	0.46	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	3.78	2.70	1.62	0.90	0.36	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	11.44	5.67	1.75	1.65	1.96	2.58	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	15.14	6.52	2.10	2.10	1.40	0.93	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	21.11	13.43	4.16	0.32	0.32	2.24	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	7.89	8.45	1.13	1.69	0.56	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	6.12	7.24	1.30	0.93	0.37	1.30	0.37
CD14+ Monocytes, donor3	11381-118B4	13.39	10.98	2.63	1.32	0.44	0.66	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	2.26	9.91	1.98	1.13	1.13	0.85	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	5.69	11.75	1.14	0.76	1.14	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	2.30	12.16	0.66	0.99	0.66	1.64	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	7.23	9.68	1.01	1.16	0.43	1.01	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	3.92	7.24	0.91	0.91	0.00	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	7.58	8.05	1.66	1.18	0.95	0.71	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.68	6.70	1.51	0.50	0.67	1.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2.76	4.97	1.38	0.00	0.00	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4.96	5.70	0.50	0.74	0.50	0.74	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.70	5.87	1.37	1.17	0.00	0.39	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3.38	3.20	1.25	0.00	0.18	0.89	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	3.48	10.45	2.83	1.31	0.22	0.65	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.98	5.62	1.17	0.70	0.00	1.17	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.86	3.17	1.58	0.00	0.00	1.58	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	3.33	4.44	1.11	1.11	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	6.69	6.25	1.64	1.64	0.45	1.78	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.19	5.79	0.60	1.40	0.00	1.20	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	4.58	11.03	2.29	1.67	0.42	0.83	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	3.89	4.58	0.69	1.14	0.23	0.46	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2.94	6.11	0.45	0.90	0.00	0.45	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	2.18	5.67	1.75	0.00	0.00	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.57	5.92	2.15	0.81	0.27	1.88	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	4.19	4.54	2.09	0.87	0.17	0.52	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.89	5.89	2.52	2.10	0.42	1.26	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1.84	4.23	0.55	1.10	0.18	0.73	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	3.17	2.47	0.35	0.70	0.00	1.76	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.95	7.02	0.88	0.00	0.00	1.32	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.36	5.41	1.39	2.09	0.17	1.05	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	2.97	4.46	0.74	0.74	0.00	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	5.39	11.21	1.72	1.51	0.00	0.00	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1.23	5.32	1.23	0.00	0.00	1.23	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1.62	3.94	0.46	1.16	0.00	0.46	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	5.10	10.21	1.62	1.16	0.00	0.70	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	9.59	20.71	4.80	1.53	1.31	1.09	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	9.01	18.02	5.08	2.31	1.15	1.85	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	14.51	25.34	3.68	1.95	1.30	0.87	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	11.37	23.67	3.27	3.27	0.93	1.71	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	10.48	16.77	3.14	2.97	1.92	2.27	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	6.02	17.61	2.23	0.45	0.00	1.56	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	18.88	23.73	4.85	1.79	3.57	3.57	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	14.05	16.25	4.17	2.63	1.54	1.10	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	14.11	24.00	3.37	1.89	1.26	2.53	1.26
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	38.61	20.32	2.03	0.00	4.06	2.03	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	27.80	18.31	4.07	2.71	1.36	2.03	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	27.96	32.10	4.14	4.14	4.14	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	21.85	19.72	5.86	1.60	3.73	2.67	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	28.95	21.44	6.43	3.75	3.75	3.22	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	20.36	25.27	3.51	2.11	7.02	2.81	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	23.53	19.61	8.63	1.57	3.14	1.57	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	34.28	27.68	2.64	2.64	3.95	1.32	2.64
CD19+ B Cells, donor1	11544-120B5	13.15	18.08	2.47	0.00	2.47	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	9.43	10.88	1.45	1.45	2.18	1.45	1.45
CD19+ B Cells, donor3	11705-123B4	10.10	14.64	2.02	2.52	2.52	2.02	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	7.27	15.76	3.23	6.06	0.81	3.23	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	4.79	15.98	4.39	6.39	0.40	5.19	0.40
CD34+ Progenitors, donor1	11545-120B6	15.06	5.02	4.02	2.01	0.00	2.01	1.00
CD34+ Progenitors, donor2	11625-122B5	17.98	16.29	3.37	0.00	0.56	1.12	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	11.65	14.28	3.01	2.63	0.75	2.25	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	16.91	11.27	3.16	2.93	1.35	1.58	0.90
CD4+ T Cells, donor1	11225-116C1	22.49	21.42	2.86	3.57	2.86	3.57	1.07
CD4+ T Cells, donor2	11306-117C1	21.43	18.37	5.51	1.84	0.00	3.06	0.00
CD4+ T Cells, donor3	11382-118B5	25.31	18.30	2.74	1.83	2.74	1.83	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	21.95	22.46	7.15	6.13	2.30	3.57	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	21.79	25.60	7.41	3.14	2.47	2.25	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	19.26	27.88	6.04	4.31	2.30	1.72	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	31.76	43.62	7.11	0.95	2.37	3.79	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	41.44	48.46	9.13	5.62	4.21	3.51	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	46.15	0.00	6.59	3.30	6.59	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	18.79	15.75	4.19	2.17	2.02	1.30	1.01
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	20.67	18.81	5.42	2.54	4.07	0.85	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	17.09	16.12	4.19	2.90	1.77	0.97	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	21.52	31.83	14.79	2.69	2.69	4.93	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	26.90	41.93	6.29	4.89	2.80	2.10	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	21.56	30.36	4.40	3.52	1.76	2.20	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	15.60	24.03	2.95	2.11	3.37	2.53	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	13.09	17.45	2.91	0.62	2.91	1.04	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	10.69	20.72	5.35	3.34	1.00	1.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	30.73	32.63	7.89	3.54	1.36	2.45	1.90
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	19.83	39.12	5.36	3.75	1.07	1.61	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	30.48	23.31	5.38	5.38	3.59	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	21.88	15.02	6.86	2.78	4.45	2.60	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	17.98	16.90	4.12	2.17	5.20	1.73	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	21.65	22.49	5.88	3.78	5.04	2.10	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	28.31	26.29	8.09	3.54	3.03	3.03	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	36.39	32.49	9.53	5.20	3.03	2.17	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	17.87	31.81	6.54	2.18	2.18	3.05	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	39.09	32.17	7.42	1.48	1.48	2.97	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	32.31	28.62	4.62	4.62	3.69	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	23.73	30.71	8.37	1.40	0.00	8.37	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	20.77	28.80	10.80	3.32	4.98	5.54	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	24.78	26.26	6.87	3.68	3.19	4.17	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	16.94	36.96	4.62	1.54	4.62	4.62	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	25.78	27.22	3.58	3.22	3.58	5.01	2.51
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	47.09	27.70	2.77	5.54	5.54	8.31	0.00
CD8+ T Cells, donor1	11226-116C2	27.83	17.68	4.26	2.62	0.65	3.27	1.31
CD8+ T Cells, donor2	11307-117C2	27.78	12.76	1.50	3.38	1.50	1.50	1.13
CD8+ T Cells, donor3	11383-118B6	32.32	15.15	3.03	4.80	1.26	3.53	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	8.72	7.80	1.38	1.61	1.15	0.46	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	6.23	5.51	2.16	0.72	1.20	0.96	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	8.48	5.47	1.64	1.37	2.74	1.64	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.90	6.30	2.10	2.70	1.50	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.48	6.48	2.88	0.48	1.68	0.96	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	6.37	4.55	3.18	0.45	1.82	0.68	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.65	6.95	1.74	0.65	1.96	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	8.69	3.95	3.16	0.26	1.84	1.32	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	6.33	4.46	1.64	1.17	1.64	0.94	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	9.66	7.25	3.02	1.51	1.51	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.10	5.81	3.49	1.16	3.20	1.16	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	8.53	5.86	1.60	1.07	1.33	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	6.13	3.94	2.19	0.44	3.50	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	7.74	4.10	0.46	1.37	1.37	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	7.46	2.98	0.00	0.00	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.04	6.48	3.60	0.72	1.44	2.16	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	7.19	6.33	2.30	0.86	1.15	0.86	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	5.89	6.84	1.41	0.24	1.65	0.94	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	9.51	5.39	1.27	0.95	0.63	1.58	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.92	5.54	0.62	0.31	2.15	0.92	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	4.49	6.09	1.60	1.28	0.96	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	7.65	5.35	0.76	0.76	1.53	0.76	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.09	3.15	1.97	0.79	2.76	0.00	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	5.29	9.08	0.76	1.51	3.78	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	16.86	8.03	5.62	0.00	6.42	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	14.69	9.09	5.60	1.40	3.50	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	10.02	13.02	3.01	3.01	3.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	3.66	1.83	1.83	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	9.39	7.41	0.99	0.49	0.49	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	4.53	6.00	1.05	0.42	0.53	0.11	0.21
Chondrocyte - de diff, donor1	11261-116G1	5.55	5.55	1.73	0.00	0.00	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	7.82	6.40	1.42	0.71	1.07	0.00	1.42
Chondrocyte - de diff, donor3	11410-118E6	4.55	6.14	0.46	0.34	0.34	0.00	0.34
Chondrocyte - re diff, donor2	11339-117F7	2.69	4.48	0.00	0.90	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	4.85	7.68	0.81	0.81	1.21	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	4.48	5.05	1.38	2.18	1.03	0.46	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	4.70	3.42	1.92	1.50	0.43	1.07	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	5.04	3.45	0.71	1.06	1.15	0.53	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	6.60	11.28	0.83	2.66	1.01	8.99	0.83
Corneal Epithelial Cells, donor1	11526-119I5	10.98	10.76	0.88	2.85	0.66	0.66	0.44
Corneal Epithelial Cells, donor2	11606-120I4	10.24	6.83	0.00	3.41	3.41	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	11.76	7.16	3.58	1.53	1.02	1.28	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	6.27	10.57	1.65	1.49	0.99	0.99	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	6.94	9.78	1.58	0.95	0.95	0.63	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	6.90	0.00	0.00	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	3.46	6.16	0.86	0.86	0.32	0.43	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	10.93	16.40	3.07	1.37	1.37	2.05	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	14.36	14.36	5.88	3.92	1.31	3.92	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	11.61	17.42	2.42	1.45	2.90	2.42	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	7.34	4.84	1.17	1.00	0.83	0.33	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	9.39	2.35	1.76	0.59	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	7.35	3.39	1.70	2.55	1.13	0.28	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	7.86	5.11	0.39	0.79	0.79	0.79	0.79
Endothelial Cells - Artery, donor1	11264-116G4	7.85	2.91	1.45	2.04	0.87	0.29	0.58
Endothelial Cells - Artery, donor2	11341-117F9	11.29	5.41	2.12	1.41	1.65	0.94	0.00
Endothelial Cells - Artery, donor3	11413-118E9	8.77	5.79	1.75	1.40	1.75	0.35	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	6.65	4.21	0.66	0.66	0.66	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	3.35	4.87	1.22	0.91	0.61	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	2.82	1.97	0.85	1.13	0.56	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	7.43	3.27	1.19	1.49	1.19	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	7.29	4.17	1.56	2.08	1.04	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	6.66	3.69	0.57	2.13	1.13	1.84	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	8.80	4.80	2.00	1.60	1.60	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	6.29	4.19	1.05	1.57	1.57	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	9.82	4.72	1.37	1.86	1.86	0.37	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	6.08	3.69	1.09	1.09	0.43	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	6.96	3.05	0.98	0.61	1.34	0.37	0.12
Endothelial Cells - Vein, donor1	11267-116G7	13.65	7.96	2.28	0.00	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	7.68	3.49	1.40	1.40	2.79	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	9.42	3.93	0.94	1.26	1.57	0.31	0.47
Eosinophils, donor1	12244-129H3	30.49	45.74	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	51.16	54.46	9.90	4.95	1.65	0.00	8.25
Eosinophils, donor3	12246-129H5	49.94	17.83	7.13	3.57	3.57	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	9.04	8.06	1.71	0.98	0.73	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	4.16	0.00	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	4.11	4.52	0.41	0.41	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.72	2.74	0.88	0.33	0.66	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	5.31	3.25	1.30	0.33	0.87	0.33	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	4.85	4.24	1.70	0.85	0.73	0.00	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	5.87	13.92	3.41	0.41	0.41	0.14	1.50
Fibroblast - Aortic Adventitial, donor2	11326-117E3	3.38	3.48	0.95	0.32	0.74	0.21	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	3.43	6.32	2.63	0.79	2.37	0.00	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	3.99	3.99	1.66	1.00	0.66	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	5.44	6.35	1.81	0.91	2.27	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	11.37	5.31	2.27	3.03	1.52	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	5.36	5.84	1.10	1.58	0.95	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	4.85	4.24	0.61	0.30	0.91	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	6.98	4.19	2.54	0.89	1.27	0.13	0.25
Fibroblast - Cardiac, donor6	11460-119B2	3.79	2.88	0.91	0.61	0.91	0.15	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	3.08	3.75	0.80	0.54	1.34	0.54	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	4.75	2.59	0.86	0.00	0.43	1.29	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	5.86	5.86	1.46	4.39	0.00	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	12.69	12.92	1.85	2.54	1.61	1.85	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	6.78	5.60	1.70	0.34	1.02	0.17	0.51
Fibroblast - Dermal, donor1	11269-116G9	8.22	3.05	1.64	0.94	0.00	0.47	0.70
Fibroblast - Dermal, donor2	11346-117G5	9.91	6.60	1.89	0.00	2.36	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	10.28	6.29	1.69	1.45	0.48	0.36	0.73
Fibroblast - Dermal, donor4	11450-119A1	4.86	3.96	1.36	1.47	0.79	0.57	0.11
Fibroblast - Dermal, donor5	11454-119A5	5.23	3.66	1.57	1.05	0.52	0.35	0.17
Fibroblast - Dermal, donor6	11458-119A9	2.11	5.52	0.81	1.79	0.49	0.16	0.49
Fibroblast - Gingival, donor1	11237-116D4	4.79	5.41	1.67	0.62	0.62	0.21	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	3.67	6.81	1.83	0.26	1.57	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	4.88	4.22	1.32	1.98	1.45	0.40	0.53
Fibroblast - Gingival, donor3	11394-118C8	6.86	5.22	0.87	0.77	0.48	0.48	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	4.16	1.04	2.08	1.04	0.00	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	4.76	5.81	1.23	0.70	0.88	0.18	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	5.30	5.14	1.09	0.94	0.94	0.94	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	3.52	5.54	1.35	0.68	0.54	0.41	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	4.59	8.47	0.71	0.35	1.76	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	4.39	3.95	1.17	0.15	0.73	0.29	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	3.27	4.36	1.09	0.68	0.82	0.82	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	4.06	3.73	1.43	0.44	0.22	0.44	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	2.64	6.46	0.88	1.03	0.59	0.29	0.15
Fibroblast - Lung, donor1	11270-116H1	12.23	5.44	1.36	0.00	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	2.98	8.95	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	11.18	7.81	2.53	1.48	1.06	1.27	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	8.33	5.83	2.50	0.83	4.17	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	2.80	0.00	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	8.96	8.40	2.52	1.40	1.40	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	6.50	6.90	1.62	0.00	0.81	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	0.00	7.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	3.88	4.66	1.36	2.13	0.39	0.58	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	2.12	2.88	0.46	0.15	1.21	0.61	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	2.14	3.98	0.31	0.31	0.31	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	1.91	2.29	0.38	1.14	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	5.40	6.21	1.35	1.62	0.27	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	3.13	4.18	0.93	1.16	0.81	0.23	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	5.75	4.42	1.44	1.11	0.55	0.11	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	1.83	5.28	1.63	1.02	0.81	1.22	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	5.35	2.00	0.67	0.00	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	6.72	6.72	1.98	1.19	0.79	0.40	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	5.95	6.75	1.98	0.79	0.20	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	2.13	4.62	1.24	2.13	0.53	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	2.96	5.91	0.39	0.79	0.39	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	4.81	3.61	2.11	0.60	1.50	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	2.91	4.53	0.76	0.86	0.97	0.32	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	5.06	9.11	3.80	0.25	1.27	0.76	1.01
Fibroblast - skin normal, donor1	11553-120C5	3.94	5.25	1.48	1.64	0.16	0.00	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	3.61	11.23	1.60	1.80	0.80	0.40	0.80
Fibroblast - skin normal, donor2	11561-120D4	3.21	6.13	0.60	0.60	0.70	0.30	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	5.44	11.18	3.02	0.91	0.30	0.30	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	3.15	5.47	1.33	0.58	0.41	0.25	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	4.62	5.64	1.54	0.34	0.85	0.00	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	3.94	6.90	1.97	0.33	0.66	0.66	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	3.20	2.98	1.28	0.53	0.43	0.64	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	4.55	5.57	1.69	1.18	0.84	0.51	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	4.08	5.49	0.63	2.35	0.47	0.31	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	7.84	1.74	0.87	0.87	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	5.55	3.47	2.95	1.56	1.39	0.35	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	6.51	6.25	1.30	0.52	0.78	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	8.69	4.34	1.53	0.77	1.28	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	11.48	2.30	1.53	1.53	3.06	3.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	13.40	4.47	3.19	1.28	3.19	3.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	10.84	1.43	1.43	5.71	5.13	1.43	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	8.00	2.21	1.10	3.31	8.55	9.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	3.88	2.97	0.46	1.37	6.39	4.57	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	5.75	2.97	1.59	2.97	6.74	1.78	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	8.19	1.85	1.06	3.17	12.16	8.72	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	4.24	2.94	0.33	1.30	6.85	3.91	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	10.17	4.42	0.88	1.77	3.98	6.19	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	6.64	2.40	0.85	2.69	3.53	3.11	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	7.88	2.71	1.48	1.85	1.85	2.46	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	6.18	3.22	1.34	2.69	3.49	1.88	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	7.19	2.48	0.74	0.99	2.48	1.36	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	6.78	2.35	0.55	1.25	2.35	1.66	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	8.13	3.05	0.81	1.02	3.25	1.63	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	7.53	3.65	1.83	2.51	3.65	1.60	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	7.60	1.99	1.12	2.12	2.99	1.74	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	6.78	1.53	0.87	0.44	1.97	1.31	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	7.98	5.02	0.59	0.89	3.84	3.55	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	5.88	4.13	0.79	2.38	3.50	2.07	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	3.80	3.13	0.22	2.46	3.13	2.46	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	3.02	2.62	1.21	2.22	3.23	3.02	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	4.41	3.39	0.85	1.53	2.88	1.53	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	6.21	3.28	0.44	2.39	2.31	1.42	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	7.70	3.64	0.42	1.98	2.19	1.56	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	4.78	3.24	0.85	3.59	2.90	2.22	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	3.76	2.77	0.89	1.00	3.54	2.32	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	6.16	3.66	1.16	2.66	2.41	1.58	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	6.33	2.86	0.61	1.84	1.43	2.04	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	6.40	3.30	0.83	2.68	2.68	2.27	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	5.42	3.69	0.58	3.23	2.19	1.50	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	6.00	4.34	0.83	3.00	4.17	1.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	4.19	2.87	0.66	2.87	2.42	1.32	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	5.90	4.06	0.61	2.83	3.07	1.97	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	5.02	3.57	1.13	2.76	3.24	2.27	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	6.41	3.53	0.96	1.92	2.57	2.89	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	5.21	4.26	0.66	2.94	2.75	2.18	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	4.11	4.27	0.47	1.74	2.06	1.74	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	4.26	2.43	0.91	1.82	2.74	0.91	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	4.39	2.72	1.25	1.99	1.78	1.67	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	7.25	4.61	0.66	1.98	2.20	2.42	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	7.86	3.93	0.28	1.96	2.81	0.84	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	4.72	3.52	1.76	1.02	1.48	1.20	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	6.69	3.48	0.80	2.41	1.34	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	5.66	3.37	1.07	2.14	2.45	0.46	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	4.92	3.50	1.81	2.20	2.46	1.55	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	8.67	3.52	2.44	4.34	2.71	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	4.42	5.53	1.29	1.29	3.13	1.29	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	5.48	3.95	0.44	1.97	4.82	1.97	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	3.97	0.99	1.98	0.00	2.98	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	4.22	2.90	0.66	1.58	1.71	1.06	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	3.63	3.23	1.01	1.61	1.01	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	3.30	3.56	0.51	1.78	0.76	0.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	7.17	1.59	0.60	5.57	6.97	2.79	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	6.32	1.85	0.62	2.31	2.77	4.31	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	6.96	1.84	1.23	2.05	5.32	4.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	11.58	2.82	0.63	4.69	5.32	1.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	11.02	4.24	2.26	4.80	2.54	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	8.30	3.23	0.00	1.38	7.84	2.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	4.95	2.47	2.47	7.42	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	11.60	3.48	2.32	3.48	2.71	2.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	3.21	3.21	1.60	0.00	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	13.91	0.00	1.74	1.74	1.74	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	6.18	1.30	0.98	3.25	5.86	3.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	7.41	1.24	1.24	4.12	3.71	2.06	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	3.33	0.00	0.00	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	3.36	2.80	1.40	3.92	2.80	1.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	4.90	2.61	0.33	2.29	4.25	2.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	5.87	1.68	0.00	2.52	4.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	7.32	1.59	1.91	3.82	2.54	1.91	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	5.77	1.36	1.70	1.36	4.08	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4.18	2.09	0.00	2.09	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	4.01	1.15	1.15	4.01	5.15	3.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	6.22	2.07	0.30	2.37	3.85	1.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	8.47	1.69	0.00	0.00	6.78	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	11.60	2.90	1.24	4.97	4.14	2.90	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	5.06	1.84	0.69	2.53	6.67	3.45	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	0.00	0.00	10.54	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	3.46	1.92	0.77	3.46	6.54	3.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	5.54	1.30	0.33	3.26	3.59	1.63	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	4.01	2.01	0.67	2.01	2.01	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	5.78	1.16	1.16	5.39	7.32	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	7.19	2.74	0.68	3.08	0.68	3.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	12.42	0.00	0.00	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	2.83	0.47	1.42	3.77	8.02	3.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	7.24	0.60	1.21	4.22	2.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	4.58	3.56	0.00	2.54	5.60	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	5.58	0.80	0.80	5.18	5.18	2.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	3.95	2.96	0.99	2.96	3.45	1.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	7.08	0.00	1.18	7.08	7.08	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	7.58	1.17	0.58	1.75	2.92	2.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	5.71	1.76	0.00	3.95	3.95	1.76	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	5.93	0.85	1.70	2.54	2.54	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	3.58	5.37	1.79	3.58	2.39	2.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	5.34	1.94	1.46	3.40	2.43	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	4.57	7.99	2.28	2.28	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	3.33	7.07	1.66	1.66	1.25	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	14.62	10.12	1.12	4.50	2.25	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	6.98	3.81	2.54	0.63	1.59	0.32	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	11.28	4.60	2.92	1.67	0.00	0.42	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	4.87	3.13	1.04	0.46	0.23	0.46	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	4.39	2.36	0.68	0.84	0.68	0.84	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	2.96	4.78	0.46	1.14	0.46	1.82	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	3.28	2.84	0.98	0.66	0.77	0.66	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	4.08	5.16	0.43	0.86	0.43	0.21	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	2.80	4.52	1.29	0.65	0.43	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	6.60	4.86	0.12	1.12	0.62	0.37	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	5.15	2.74	1.37	1.03	0.51	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	3.84	3.84	0.96	0.32	0.00	0.96	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.07	2.24	0.56	1.68	2.24	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.19	6.06	0.43	1.73	0.87	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	0.00	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	7.76	9.52	0.71	0.35	1.06	0.00	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.81	6.54	1.45	0.73	1.45	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	8.39	5.59	2.27	1.05	1.22	0.35	0.70
Hepatocyte, donor1	11523-119I2	27.84	9.68	4.84	0.00	2.42	2.42	1.21
Hepatocyte, donor2	11603-120I1	16.16	10.77	3.23	3.23	4.31	1.08	0.00
Hepatocyte, donor3	11684-122I1	12.88	6.75	3.07	0.61	0.61	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	15.01	16.97	5.87	2.61	5.87	3.92	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	11.89	8.04	1.75	2.62	2.80	1.92	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	5.35	3.70	1.10	0.69	0.14	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	6.37	9.55	6.37	6.37	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	6.68	0.00	0.00	13.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00	0.00	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	13.84	8.31	2.77	2.77	18.00	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	10.01	5.01	2.50	17.52	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	0.00	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	7.69	12.81	2.56	23.07	15.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	9.14	13.71	4.57	22.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	22.74	14.62	6.50	3.25	14.62	4.87	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	10.00	10.00	1.67	6.67	5.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	14.52	3.63	7.26	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	35.73	17.21	9.26	1.32	26.47	3.97	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	14.41	6.65	3.33	2.22	6.65	5.54	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	26.19	5.24	0.00	20.95	10.48	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	19.53	11.97	5.04	0.63	17.01	5.67	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	17.01	10.83	9.28	1.55	17.01	4.64	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	18.09	17.44	5.81	1.29	17.44	7.11	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	24.15	19.32	14.49	3.22	12.88	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	11.95	0.00	11.95	23.90	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	27.71	14.67	2.44	1.63	25.26	5.70	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	20.99	14.69	5.46	1.26	14.27	5.04	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	12.86	14.47	6.43	0.80	19.29	8.04	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.00	12.00	3.69	1.85	12.00	1.85	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	30.16	0.00	45.24	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.05	9.91	4.72	1.89	10.86	1.89	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	16.33	14.51	8.16	1.81	16.33	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	29.48	0.00	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	27.98	22.60	15.07	0.00	22.60	9.69	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	26.68	20.33	6.35	2.54	19.06	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	22.96	14.03	9.57	1.28	18.49	6.38	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	3.65	5.47	3.65	18.23	3.65	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	15.80	31.61	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	29.99	19.28	5.71	2.86	20.71	5.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	9.95	6.64	0.00	13.27	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	17.28	7.10	4.63	2.47	13.58	1.54	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	35.12	12.29	5.27	5.27	22.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	22.00	9.43	0.00	22.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	21.56	13.21	4.87	2.78	21.56	3.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	6.64	6.64	2.21	28.77	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	9.73	6.48	6.48	9.73	6.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	17.44	13.95	4.36	0.00	35.75	8.72	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	13.50	11.25	4.50	18.00	6.75	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	13.94	6.97	0.00	10.45	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	11.73	10.67	4.27	2.13	23.47	7.47	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	20.78	11.08	8.31	1.39	19.40	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	5.70	0.00	2.85	22.80	2.85	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.01	11.97	7.36	2.76	30.37	5.52	3.68
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	9.08	0.00	0.00	15.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	18.63	0.00	0.00	24.83	6.21	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	27.49	11.63	5.29	2.11	17.98	3.17	0.00
Keratinocyte - epidermal, donor1	11272-116H3	6.94	4.90	1.47	0.57	0.49	0.16	0.41
Keratinocyte - epidermal, donor2	11349-117G8	14.64	10.54	1.17	3.51	1.17	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	6.25	4.83	1.42	1.51	1.61	0.19	0.19
Keratinocyte - oral, donor1	11251-116E9	9.54	4.54	1.36	1.02	1.02	1.14	0.34
Keratocytes, donor1	11527-119I6	9.28	14.10	2.41	2.41	1.72	0.69	1.03
Keratocytes, donor2	11607-120I5	3.52	10.55	1.17	1.17	4.69	0.00	1.17
Keratocytes, donor3	11688-122I5	5.53	6.92	1.78	0.20	1.58	0.59	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	4.40	8.79	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	8.63	10.79	1.08	2.16	1.08	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	4.73	4.15	1.61	1.96	0.81	2.08	0.12
Lens Epithelial Cells, donor3	11690-122I7	2.72	3.13	0.30	0.40	0.61	0.40	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	4.74	5.93	1.19	1.66	1.54	1.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.14	2.51	1.12	1.40	0.28	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	6.77	3.62	1.26	2.20	1.10	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	4.30	3.76	0.54	2.69	0.54	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.41	2.21	1.26	0.63	1.58	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	5.61	4.31	1.51	1.62	1.51	1.29	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.75	2.87	0.41	3.28	1.64	0.82	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.34	4.05	2.53	3.03	2.02	0.51	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.02	4.93	1.97	1.97	0.70	0.28	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	3.96	3.16	1.58	0.40	1.98	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.98	4.46	1.36	1.74	1.16	0.58	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.07	3.89	2.04	1.85	1.48	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	8.01	2.79	0.70	2.44	1.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.35	5.01	1.67	2.39	0.72	0.95	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.00	4.40	1.24	1.92	0.96	0.96	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	7.08	3.70	1.23	1.54	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	9.98	3.74	0.62	2.81	0.94	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	7.87	4.76	1.46	2.74	1.83	2.01	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.59	3.62	1.32	1.32	1.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.74	4.39	0.59	3.51	0.88	0.88	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	10.95	5.23	1.99	2.74	0.25	1.49	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.76	1.94	0.97	1.94	1.45	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.43	4.31	0.81	1.89	0.81	1.35	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.27	4.24	1.67	1.21	1.67	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.78	4.15	2.07	1.56	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.75	3.98	0.84	2.09	1.47	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.37	5.71	1.50	1.65	0.75	0.60	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.25	2.75	2.06	0.00	0.00	2.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	7.15	4.33	2.07	0.75	1.69	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.21	3.50	1.17	1.27	1.59	0.74	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	3.88	0.97	0.97	2.91	0.97	2.91	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.28	4.63	1.65	1.32	0.99	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.93	3.84	1.86	1.24	1.36	0.87	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	5.18	1.85	1.85	0.74	2.22	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	10.13	3.71	1.48	2.22	1.98	0.99	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.29	3.44	0.69	1.92	1.51	1.10	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	3.22	5.15	1.29	2.25	2.25	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.30	4.56	1.52	0.61	0.61	1.22	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.00	3.92	1.54	0.98	1.12	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	5.69	3.91	1.42	1.07	1.07	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.79	5.33	1.45	0.97	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	8.87	4.36	0.93	2.80	1.87	1.09	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	7.16	2.86	0.72	1.07	2.51	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	8.82	4.90	1.63	0.65	1.63	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.89	3.30	1.88	2.83	2.12	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	6.68	4.08	1.98	1.73	0.87	1.24	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.43	3.84	1.79	2.05	1.28	1.02	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	4.77	3.88	0.30	0.90	0.90	1.19	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	29.46	27.19	4.53	0.00	9.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	13.81	16.88	6.14	0.77	0.77	0.77	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	14.84	14.10	4.45	2.23	3.71	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	20.73	15.23	6.77	4.65	3.39	2.12	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	15.47	16.88	4.22	4.22	1.41	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.94	14.94	5.60	2.80	0.93	1.87	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	19.58	9.79	2.58	1.55	4.12	1.55	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	23.79	20.22	5.95	4.76	1.19	1.19	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	30.08	21.94	6.56	2.04	3.62	2.49	1.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.12	11.92	3.20	4.36	2.04	1.16	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	13.06	5.85	3.60	3.15	3.60	2.25	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	21.81	20.32	2.85	3.12	3.39	2.03	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	17.97	16.95	5.14	2.05	4.11	3.59	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	11.64	10.23	3.88	4.94	1.06	1.76	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	10.66	15.99	2.67	4.66	3.33	2.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.87	16.81	2.04	2.04	4.58	3.06	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	13.34	8.80	3.20	2.40	1.60	1.87	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	15.49	14.93	3.59	3.21	2.46	3.21	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	18.41	11.66	3.68	6.14	3.68	0.61	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	16.31	16.31	4.89	4.89	3.26	0.82	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.20	10.20	1.87	2.50	0.83	2.08	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	15.69	12.61	2.52	1.12	2.52	0.84	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	13.39	10.30	3.09	1.03	7.21	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	14.22	12.48	3.48	2.90	2.03	1.45	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	8.67	7.77	3.29	2.69	1.79	1.20	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.30	12.17	1.66	1.11	4.98	0.00	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	17.67	12.02	4.60	3.18	4.60	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	17.70	13.64	5.16	1.11	3.32	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	25.33	17.27	4.61	4.61	11.51	2.30	4.61
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	14.58	16.50	4.22	3.45	4.99	3.07	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	20.38	14.72	2.83	1.13	3.96	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.87	13.13	3.28	0.82	5.74	0.82	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	16.27	14.91	4.97	3.16	5.87	2.26	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.95	15.08	5.75	3.59	5.75	0.72	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	22.41	8.96	4.48	1.49	5.98	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	16.72	12.26	4.46	4.09	6.69	1.49	2.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	13.78	10.77	4.74	1.72	2.58	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	13.70	16.27	2.57	4.28	5.14	0.00	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	15.33	12.66	3.33	2.33	3.00	1.33	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	18.70	14.48	1.81	3.02	5.43	0.60	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.22	10.66	2.13	4.27	7.82	4.27	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	14.78	17.87	4.12	2.06	5.84	2.06	2.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	16.64	13.42	4.83	3.22	7.51	1.61	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	16.83	10.10	2.02	2.69	2.69	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	13.71	12.59	4.82	3.33	2.96	2.22	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	27.91	19.77	5.81	5.81	5.81	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	15.87	10.58	3.17	1.06	3.17	0.00	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	19.21	17.21	2.40	1.60	4.40	0.80	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.99	21.81	3.63	2.18	6.54	3.63	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	34.49	19.93	4.60	3.83	6.90	5.37	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	24.17	22.69	4.44	4.93	4.93	2.96	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	15.05	25.41	5.65	4.70	3.76	2.82	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	26.65	21.62	8.05	5.53	6.54	1.01	3.52
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	20.73	17.57	6.31	1.80	4.96	1.80	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	24.10	10.33	3.44	0.00	1.72	1.72	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	20.49	19.60	6.68	3.12	5.34	1.78	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	22.68	17.99	8.21	1.56	4.69	0.39	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	29.03	19.79	6.60	1.32	3.96	1.98	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	21.79	18.16	6.75	3.11	3.11	2.59	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	18.82	20.13	4.38	2.63	3.50	1.31	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	11.74	17.33	5.03	2.24	2.80	1.68	2.80
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	24.29	18.99	4.86	3.09	4.86	0.44	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	18.90	14.27	5.01	3.86	3.47	0.77	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	20.25	14.68	4.05	2.53	5.06	0.00	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	19.22	12.02	7.21	1.92	2.40	1.92	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	19.88	15.11	3.18	1.19	2.39	1.99	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	15.19	12.15	3.65	3.04	0.61	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	19.37	6.92	6.23	2.77	2.77	1.38	2.77
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	20.52	14.82	3.42	3.04	2.66	2.28	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	16.01	20.14	4.65	2.07	3.10	2.58	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	11.49	10.88	4.23	2.42	4.23	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	15.85	14.26	2.85	4.44	5.39	0.00	2.85
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	20.26	18.66	6.40	2.67	4.26	1.60	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.77	7.47	5.75	2.87	4.60	1.15	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	13.37	18.00	4.63	4.63	5.14	1.03	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	11.32	18.39	5.66	6.37	6.37	0.71	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	12.48	10.78	3.40	4.54	6.81	2.84	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	15.39	14.56	3.33	1.66	5.41	1.66	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.88	12.53	8.61	0.78	6.26	1.57	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	9.60	12.11	3.76	2.51	5.85	0.84	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	14.40	12.08	5.11	1.39	6.97	0.46	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	11.37	18.06	5.35	3.35	6.69	2.68	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	12.83	9.62	3.74	1.07	4.28	1.60	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	15.36	15.76	4.04	4.04	6.47	1.21	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.03	14.68	5.51	3.67	8.26	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	15.11	15.11	2.67	4.45	10.67	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	24.50	21.66	5.70	3.42	6.27	1.14	2.85
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	23.01	15.34	2.30	2.30	8.44	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	11.49	6.57	6.02	3.28	8.75	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	13.81	13.81	4.45	4.01	6.24	0.89	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	18.98	19.76	3.64	2.60	4.68	2.34	1.82
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.25	9.28	4.64	3.98	7.96	2.65	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	29.10	10.39	2.08	8.31	6.24	0.00	4.16
Macrophage - monocyte derived, donor1	11232-116C8	2.28	7.98	1.37	1.60	0.46	1.37	0.00
Macrophage - monocyte derived, donor2	11313-117C8	1.84	6.79	1.10	1.28	0.37	0.37	0.55
Macrophage - monocyte derived, donor3	11389-118C3	2.75	4.85	1.31	1.18	1.05	0.66	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	6.90	3.19	1.59	1.06	2.66	1.06	0.53
Mallassez-derived cells, donor2	11929-125I3	3.80	5.55	1.58	1.74	1.58	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	7.23	5.14	3.06	2.22	2.36	0.56	0.69
Mammary Epithelial Cell, donor1	11273-116H4	10.76	7.87	1.99	1.89	1.20	0.60	0.80
Mammary Epithelial Cell, donor2	11350-117G9	7.82	6.95	1.74	1.16	0.29	0.00	1.16
Mammary Epithelial Cell, donor3	11422-118F9	14.47	2.99	1.50	2.24	2.74	0.75	0.25
Mast cell - stimulated, donor1	11487-119E2	4.07	3.39	2.03	0.68	0.68	2.03	0.00
Mast cell, donor1	11563-120D6	5.62	9.41	0.54	1.08	0.22	1.08	0.43
Mast cell, donor2	11565-120D8	5.94	14.86	1.78	2.97	0.89	1.19	2.38
Mast cell, donor3	11566-120D9	6.30	18.69	3.60	1.58	0.68	2.03	1.13
Mast cell, donor4	11567-120E1	4.61	16.13	1.60	2.48	1.60	1.95	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	3.22	8.32	1.00	0.67	1.33	1.33	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	4.09	15.76	3.50	1.75	0.00	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	5.85	14.68	2.64	1.95	1.03	1.61	0.34
Mast cell, expanded, donor8	11941-126A6	9.04	14.23	3.01	2.01	1.00	1.51	0.00
Melanocyte - dark, donor1	11502-119F8	7.96	3.48	0.70	2.29	1.39	1.49	0.10
Melanocyte - dark, donor2	11582-120F7	6.58	8.65	4.15	0.69	1.73	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	4.93	6.09	1.23	1.81	0.94	0.87	0.65
Melanocyte - light, donor1	11274-116H5	4.00	5.41	0.47	0.24	1.18	0.47	0.47
Melanocyte - light, donor2	11351-117H1	11.60	3.41	1.36	1.36	1.36	3.41	0.00
Melanocyte - light, donor3	11423-118G1	11.27	2.60	0.00	0.00	0.87	0.87	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	4.89	6.04	1.35	1.35	0.42	0.83	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	5.65	5.11	1.88	1.88	1.61	1.88	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	4.55	2.68	1.34	1.34	1.34	0.80	0.00
Meningeal Cells, donor1	11493-119E8	4.59	4.34	1.61	1.61	0.99	0.37	0.00
Meningeal Cells, donor2	11573-120E7	0.88	2.64	0.44	0.88	0.44	0.88	0.00
Meningeal Cells, donor3	11654-122E7	3.99	3.34	0.73	0.90	0.90	0.65	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	10.84	5.99	2.85	2.28	1.43	1.14	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	3.62	2.92	0.70	0.91	0.91	0.10	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	34.17	23.65	3.94	2.63	2.63	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	7.85	5.23	1.31	1.31	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.89	5.02	0.72	0.00	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	3.39	2.75	0.85	0.42	0.85	0.42	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	2.51	3.02	0.00	1.01	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.47	9.01	3.08	2.20	0.66	0.22	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	5.84	1.46	1.46	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.37	6.55	1.64	1.43	1.43	0.20	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	4.99	6.79	1.11	1.94	0.83	0.42	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.66	15.98	4.09	0.74	1.12	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	5.00	5.26	1.05	0.53	0.53	0.13	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.90	9.50	2.37	0.89	1.78	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	9.34	0.00	0.00	4.67	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	5.12	0.64	1.28	1.28	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	5.32	2.84	2.48	1.42	1.06	0.00	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	5.00	6.88	0.94	1.56	0.94	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.81	8.71	2.90	0.73	0.00	2.18	0.73
Mesothelial Cells, donor1	11247-116E5	2.39	6.10	2.39	1.06	1.06	0.53	0.00
Mesothelial Cells, donor2	12156-128G5	4.00	4.50	2.00	0.00	0.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	3.11	5.06	0.43	0.36	0.51	0.07	0.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	0.00	8.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	1.48	5.66	0.49	0.25	0.99	0.00	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	2.65	5.01	0.59	0.29	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	2.48	4.65	1.55	0.31	1.55	0.62	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	2.28	5.81	1.24	0.62	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	4.63	4.63	0.00	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	2.75	3.75	1.50	0.75	0.50	1.25	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	2.33	7.45	0.93	1.40	0.00	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	2.24	5.69	0.41	1.22	0.41	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	2.77	7.52	0.40	0.79	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.88	7.96	0.88	0.88	0.88	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	3.04	6.84	2.28	1.14	0.76	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	3.95	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	1.91	4.67	1.27	1.06	0.64	0.64	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	2.76	0.92	0.00	0.00	0.00	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	2.38	2.38	0.60	1.19	1.19	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	1.76	4.01	0.00	0.75	0.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	1.90	4.04	0.71	0.24	0.24	0.00	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1.66	6.08	0.55	0.00	0.55	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	2.76	3.22	0.46	0.92	0.46	0.46	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	2.10	4.00	1.05	0.00	0.42	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	1.22	4.48	1.22	0.41	0.00	0.82	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1.29	4.08	1.29	0.64	0.86	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	0.89	3.11	0.67	0.22	0.22	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1.75	4.16	0.88	0.44	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.53	2.53	1.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	3.31	0.00	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	2.45	2.45	1.09	0.54	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.06	3.53	1.18	0.59	0.59	0.59	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	1.09	1.09	0.00	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1.92	3.84	1.92	1.44	0.48	1.44	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	0.80	4.40	0.40	0.00	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	2.74	1.37	1.37	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.50	5.01	0.00	1.00	0.00	0.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	6.12	0.00	0.00	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3.50	7.44	0.88	0.44	1.75	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	4.41	1.10	1.10	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.20	3.84	0.64	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	1.74	3.47	0.74	0.99	0.00	0.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.78	3.48	0.00	0.00	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	2.21	2.21	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	3.76	7.52	0.34	2.74	1.03	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.75	4.38	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1.78	4.62	1.07	0.36	0.00	1.42	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3.65	5.33	0.84	0.84	0.84	1.68	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1.25	7.07	1.25	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.66	1.75	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	2.41	3.92	0.00	0.30	0.00	0.60	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	2.92	3.76	0.83	0.42	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	1.85	3.69	2.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	0.57	7.40	1.14	1.14	1.14	0.57	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	1.93	2.35	1.11	0.97	0.28	0.55	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	5.18	4.15	1.30	0.52	0.78	1.04	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.43	3.43	1.29	0.00	0.43	1.29	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.18	6.99	0.64	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	3.47	1.60	0.53	0.80	0.27	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	2.99	6.29	2.69	0.60	0.90	0.90	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	2.12	4.66	1.13	0.85	0.28	1.13	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	2.23	2.23	0.96	0.00	0.32	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	4.20	4.42	0.88	0.66	0.66	1.11	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1.52	2.65	0.76	0.76	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	3.41	5.97	1.42	1.70	0.57	0.85	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	3.69	5.90	2.46	0.74	0.74	0.98	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.21	2.61	1.30	0.65	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	2.35	2.35	1.47	1.76	0.88	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	4.61	5.48	1.15	2.02	0.58	1.15	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	2.06	2.89	0.82	1.65	0.00	1.24	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	2.68	5.66	1.19	2.08	0.89	0.89	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	3.77	0.00	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	7.13	0.00	3.56	0.00	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	2.30	4.60	2.30	2.30	1.64	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	3.16	4.21	1.05	3.16	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	2.37	5.14	1.19	1.78	0.79	0.59	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	3.73	7.45	2.79	1.86	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1.13	5.26	0.75	1.88	1.50	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	2.93	6.66	1.33	1.07	1.60	1.07	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	2.83	6.22	1.47	1.70	0.23	1.02	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.74	5.16	1.47	0.74	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	2.93	4.76	0.37	0.73	0.00	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	3.11	4.67	0.00	1.56	1.56	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.00	3.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	2.02	7.07	1.01	0.00	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	1.69	2.53	0.00	0.00	0.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	0.00	0.00	2.72	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	1.27	0.00	0.64	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.81	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	3.02	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	11.42	0.00	5.71	11.42	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	6.52	0.00	0.00	16.31	0.00	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	4.75	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	12.55	12.55	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	2.80	4.52	1.94	1.29	0.65	0.22	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	3.66	3.66	0.52	0.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	5.34	1.33	0.67	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	4.59	3.76	1.67	0.00	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	2.28	4.37	0.57	0.95	0.76	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	6.38	0.00	0.00	3.19	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.72	0.68	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	3.68	1.84	0.00	1.84	0.00	1.84	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.02	2.51	0.42	0.42	0.42	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.97	4.65	0.70	0.23	1.16	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	2.16	2.70	0.00	0.54	0.54	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	2.10	5.26	1.05	0.00	1.26	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	4.47	3.97	0.50	0.50	0.50	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	6.50	2.44	0.54	0.81	0.27	0.27	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.03	3.40	0.91	0.23	0.68	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	2.94	3.27	0.49	0.16	0.82	0.00	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	2.92	3.46	0.36	0.36	0.00	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	3.71	3.71	2.12	0.00	1.59	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	3.60	1.20	0.60	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	4.92	3.61	0.33	0.00	0.33	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.58	3.42	0.49	0.49	0.65	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	1.59	2.65	1.06	0.35	0.53	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.92	4.22	2.11	1.41	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	4.14	2.76	0.92	0.92	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	2.25	1.61	0.64	0.00	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	4.48	2.76	0.00	0.69	1.03	0.00	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	10.11	7.59	0.00	0.00	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	3.56	2.45	0.45	0.00	0.89	0.22	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	2.54	3.39	1.27	0.42	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	3.32	2.37	0.71	0.24	0.47	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	1.29	3.86	0.86	0.00	1.72	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	2.00	2.33	0.67	0.33	0.67	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	1.80	2.71	0.90	0.00	0.90	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	0.40	2.38	0.00	0.00	0.40	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	1.86	2.79	0.00	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	2.27	1.14	1.14	0.00	0.00	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	2.28	2.93	0.65	0.65	0.65	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	1.31	2.61	0.44	0.00	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	1.81	3.62	0.45	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	0.00	2.65	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.32	0.66	0.00	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	2.48	4.46	0.99	0.00	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	0.38	3.06	1.53	0.00	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	3.33	7.26	1.51	0.30	1.21	0.00	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	1.77	2.87	0.66	0.22	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.03	5.42	0.68	1.36	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	15.33	0.00	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	3.66	3.05	1.83	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	2.83	3.46	0.94	0.00	0.31	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	1.51	2.72	0.30	0.00	0.61	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	2.37	2.37	0.00	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	2.27	3.40	2.27	1.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	0.00	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	4.47	5.59	1.12	0.87	0.12	0.37	0.50
Myoblast, donor2	11322-117D8	4.22	4.41	0.58	0.77	1.53	0.19	0.58
Myoblast, donor3	11398-118D3	2.69	5.04	1.01	1.01	0.17	0.67	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	18.53	8.17	2.19	1.46	2.92	1.02	0.29
Natural Killer Cells, donor1	11230-116C6	21.83	17.22	3.08	2.15	0.92	1.85	0.92
Natural Killer Cells, donor2	11311-117C6	20.20	20.81	2.71	1.51	2.41	1.51	1.21
Natural Killer Cells, donor3	11387-118C1	22.45	14.36	3.13	2.02	1.10	2.58	1.10
Neural stem cells, donor1	11275-116H6	5.08	2.90	0.36	1.45	0.36	0.73	0.36
Neural stem cells, donor2	11352-117H2	7.70	7.70	0.00	3.85	1.93	9.63	0.00
Neurons, donor1	11494-119E9	17.07	10.24	2.28	1.14	4.55	4.55	1.14
Neurons, donor2	11574-120E8	11.89	11.23	2.64	1.76	3.30	4.40	0.22
Neurons, donor3	11655-122E8	5.76	5.76	1.64	0.82	0.82	6.58	0.00
Neutrophils, donor1	11233-116C9	18.56	21.34	4.64	0.93	0.93	0.00	0.93
Neutrophils, donor2	11314-117C9	8.70	26.09	5.80	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	13.44	23.21	3.05	1.22	1.22	0.00	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	5.34	5.22	0.83	0.36	0.47	0.24	0.95
Nucleus Pulposus Cell, donor2	11409-118E5	11.72	5.54	1.30	0.65	0.98	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	7.42	5.62	1.60	0.80	1.20	0.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	3.44	2.62	0.69	0.28	0.96	0.55	0.00
Olfactory epithelial cells, donor2	11934-125I8	4.63	4.20	1.16	0.43	0.14	0.29	0.72
Olfactory epithelial cells, donor3	11935-125I9	3.75	4.43	0.79	0.23	0.45	0.34	0.45
Olfactory epithelial cells, donor4	11936-126A1	2.82	3.70	0.58	0.29	0.29	0.10	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	7.22	6.62	0.60	0.00	1.20	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	4.68	6.17	1.06	0.85	0.43	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	3.43	6.86	4.57	2.29	1.14	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	10.55	8.07	2.48	1.86	0.62	0.62	1.24
Osteoblast, donor1	11277-116H8	10.36	9.38	2.54	1.17	1.56	0.98	0.20
Osteoblast, donor2	11354-117H4	0.70	4.21	0.00	0.70	0.70	0.00	0.70
Osteoblast, donor3	11426-118G4	6.40	5.69	1.24	0.71	1.60	0.89	1.24
Pancreatic stromal cells, donor1	11249-116E7	5.56	4.80	0.84	1.18	1.01	0.34	0.51
Pericytes, donor1	11491-119E6	7.79	6.34	2.23	2.45	1.22	1.22	0.67
Pericytes, donor2	11571-120E5	4.98	6.56	1.81	2.04	0.91	0.68	0.00
Pericytes, donor3	11652-122E5	3.87	5.29	1.83	0.61	1.02	0.20	0.41
Perineurial Cells, donor1	11499-119F5	3.73	3.84	0.68	0.79	0.90	0.34	0.11
Perineurial Cells, donor2	11579-120F4	10.31	6.26	1.66	0.92	0.46	0.09	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	9.56	17.21	2.55	1.27	1.27	1.27	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	12.24	12.73	2.45	2.20	1.47	1.47	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	9.45	9.45	1.68	1.42	0.65	1.16	0.39
Placental Epithelial Cells, donor1	11278-116H9	10.28	21.76	2.39	3.11	1.20	0.72	0.96
Placental Epithelial Cells, donor2	11355-117H5	3.33	11.09	3.33	1.11	1.11	0.00	3.33
Placental Epithelial Cells, donor3	11427-118G5	5.69	6.09	1.18	1.77	0.98	0.79	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	1.58	5.06	1.90	0.00	0.00	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	3.56	4.88	1.13	0.75	0.19	0.38	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	2.61	6.00	2.22	0.39	0.78	0.26	0.39
Preadipocyte - breast, donor2	11328-117E5	3.38	5.40	0.90	0.45	0.68	0.00	0.68
Preadipocyte - omental, donor1	11468-119C1	2.45	3.94	0.85	0.53	0.53	0.11	0.43
Preadipocyte - omental, donor2	11329-117E6	4.36	3.49	0.87	0.87	1.31	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	4.15	3.58	2.15	0.43	0.29	0.00	0.43
Preadipocyte - perirenal, donor1	11469-119C2	3.94	9.84	0.98	0.00	1.97	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	12.59	8.60	2.46	1.23	1.54	0.00	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	2.66	4.78	1.06	1.24	0.53	0.00	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	6.81	5.79	1.87	0.85	0.51	0.17	0.85
Preadipocyte - visceral, donor1	11280-116I2	3.82	5.50	1.68	0.56	0.09	0.28	0.19
Preadipocyte - visceral, donor2	11357-117H7	5.06	2.30	0.92	1.38	0.92	0.00	0.92
Preadipocyte - visceral, donor3	11429-118G7	3.87	4.81	1.46	1.04	0.52	0.00	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	12.22	6.03	1.06	3.02	3.92	2.26	0.45
Prostate Epithelial Cells, donor2	11331-117E8	6.09	4.60	1.22	0.41	0.95	0.00	0.54
Prostate Epithelial Cells, donor3	11404-118D9	2.69	4.23	0.98	0.61	1.65	0.37	0.43
Prostate Stromal Cells, donor1	11254-116F3	4.33	7.63	1.82	0.68	0.57	0.34	0.57
Prostate Stromal Cells, donor2	11332-117E9	5.02	7.17	1.08	1.43	0.72	0.00	0.90
Prostate Stromal Cells, donor3	11405-118E1	5.21	6.57	0.94	0.73	0.42	0.00	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	7.30	5.47	1.46	2.92	1.82	1.46	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	4.51	2.98	0.76	2.84	1.04	0.76	0.07
Renal Epithelial Cells, donor1	11517-119H5	10.14	8.62	2.54	4.57	3.55	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	9.25	4.27	0.71	4.27	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	6.03	3.28	1.16	2.43	0.85	1.27	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.17	3.40	1.36	0.00	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.62	3.77	1.48	1.48	1.21	0.67	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	5.77	3.55	0.22	0.89	1.11	0.67	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.99	2.66	1.33	1.33	3.33	2.66	0.67
Renal Mesangial Cells, donor1	11518-119H6	8.58	3.08	1.98	3.30	0.88	0.66	0.22
Renal Mesangial Cells, donor2	11598-120H5	5.64	7.52	1.88	5.64	0.63	1.88	0.00
Renal Mesangial Cells, donor3	11679-122H5	8.60	4.44	0.83	2.22	2.22	2.77	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	6.71	5.10	1.61	1.61	1.88	1.34	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	4.22	2.95	2.53	0.84	1.69	1.69	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	6.94	4.44	1.16	2.12	0.58	0.77	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	5.70	4.93	0.78	1.81	0.26	2.59	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	11.37	6.25	1.14	1.99	1.14	0.57	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	3.09	1.03	1.03	1.03	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	5.77	6.02	2.26	2.76	1.00	1.25	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	8.42	7.75	1.87	1.60	2.81	0.80	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	3.57	9.83	0.00	0.00	2.68	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1.65	1.10	0.00	1.65	2.20	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	2.32	2.32	0.00	1.74	0.58	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	3.25	2.86	0.91	1.17	2.86	1.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	4.57	2.98	0.60	1.09	2.28	0.60	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	6.25	5.13	1.00	2.12	2.23	1.78	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	3.47	2.60	0.74	1.74	1.24	1.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	5.36	3.26	1.05	1.05	2.68	1.63	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	4.16	4.16	0.46	2.31	1.85	1.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	2.46	2.19	1.92	0.96	3.01	1.23	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	3.48	2.87	1.21	0.76	1.82	1.51	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	6.63	3.23	0.90	1.61	2.15	1.97	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	3.44	2.73	1.15	1.86	3.01	1.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	4.94	2.04	1.61	1.18	1.72	1.72	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	6.64	4.65	0.89	1.55	2.66	1.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	2.49	1.34	0.19	0.96	1.91	1.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	3.17	2.61	0.75	1.30	2.42	1.30	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	4.70	3.76	1.50	0.94	3.95	1.69	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	3.45	1.99	0.66	0.27	3.05	1.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	2.82	2.63	1.07	0.97	2.14	2.04	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	5.54	2.48	1.34	1.53	1.91	1.53	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	2.35	1.92	0.85	1.07	2.03	1.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	4.20	3.36	1.12	1.68	2.52	1.12	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	4.61	5.30	1.54	0.68	3.59	1.71	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	3.83	2.19	1.28	0.73	2.55	1.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	5.15	3.19	1.10	1.47	2.58	2.45	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	4.57	4.03	1.34	2.42	3.22	1.75	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	3.30	1.65	1.65	1.65	1.65	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	2.98	2.98	1.19	0.60	1.59	1.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	5.85	5.61	1.40	1.64	2.81	1.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	3.53	2.49	1.24	2.49	2.90	1.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	5.09	3.32	0.88	1.11	1.33	2.21	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	4.18	5.01	0.84	1.04	3.97	1.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	2.69	3.10	1.48	1.21	1.75	2.29	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	5.45	3.07	1.53	1.02	1.19	2.04	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	5.40	3.28	1.35	1.74	1.74	1.74	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	1.20	1.72	1.55	1.20	1.55	2.41	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	5.62	3.70	0.96	0.96	1.23	0.69	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	3.61	3.61	1.15	1.81	2.46	1.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	4.94	2.39	0.51	2.39	3.07	1.19	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	5.92	3.85	0.89	1.04	1.63	2.22	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	3.47	2.13	0.80	1.33	4.00	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	3.87	1.80	0.83	0.69	3.32	1.52	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	4.76	2.14	2.14	2.38	3.81	3.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	4.43	3.43	0.81	1.81	5.44	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	5.18	2.54	1.04	1.88	3.11	1.13	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	7.69	2.45	1.05	1.05	3.49	3.49	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	5.14	1.81	0.91	0.91	1.21	2.72	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	4.77	1.96	0.73	2.20	3.55	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	5.97	7.71	1.75	2.04	2.91	4.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	12.78	2.43	1.22	1.22	3.65	3.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	6.93	1.81	0.90	1.81	3.92	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	8.37	4.30	1.58	2.04	3.85	2.26	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	6.59	5.09	1.20	4.19	5.09	1.80	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	6.73	6.85	1.89	1.65	3.66	1.89	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	9.61	5.55	2.56	1.28	5.34	1.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	3.61	3.61	0.60	0.60	7.21	0.60	0.00
Schwann Cells, donor1	11498-119F4	8.65	6.02	1.88	1.32	1.50	0.56	0.75
Schwann Cells, donor2	11578-120F3	3.40	6.80	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	6.13	6.57	1.31	1.97	1.31	0.44	0.00
Sebocyte, donor1	11220-116B5	6.03	4.93	0.55	1.64	2.19	0.00	1.10
Sebocyte, donor2	11301-117B5	5.51	3.68	1.38	0.00	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	5.15	4.33	1.24	0.21	0.62	0.00	1.24
Sertoli Cells, donor1	11255-116F4	8.28	6.63	3.31	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	2.82	8.47	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	9.77	6.95	1.58	1.67	0.88	0.53	0.44
Skeletal Muscle Cells, donor2	11358-117H8	11.57	9.40	0.72	2.17	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.03	6.69	3.34	2.51	3.34	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	5.97	4.71	1.41	0.94	1.57	0.47	0.63
Skeletal Muscle Cells, donor5	11455-119A6	4.31	4.31	1.34	0.45	1.04	0.30	0.74
Skeletal Muscle Cells, donor6	11459-119B1	5.23	3.39	1.85	1.08	1.23	0.15	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	6.93	7.31	2.02	2.02	1.13	0.63	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	7.42	7.85	1.85	0.86	1.14	1.00	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	6.05	4.17	1.49	0.69	1.09	0.50	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	3.54	4.80	0.67	1.52	1.01	0.51	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	15.92	9.41	2.90	1.45	0.72	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.47	4.27	0.69	1.65	1.38	0.96	0.55
Skin - palm, donor1	10286-104F7	0.00	10.74	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	8.22	5.62	2.31	0.29	1.30	0.29	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	13.90	19.63	11.45	0.82	5.73	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.75	4.41	1.69	0.65	1.82	0.13	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	7.09	7.92	1.25	1.39	1.39	0.14	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	6.75	3.80	0.84	0.84	1.27	0.28	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	15.01	10.57	4.23	1.48	5.07	0.85	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	2.10	3.60	1.05	0.60	0.90	0.60	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.94	2.16	0.62	0.62	1.54	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	1.33	5.34	1.33	0.22	2.00	0.67	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	11.17	9.41	1.76	1.18	0.59	0.59	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	8.62	6.41	1.99	0.00	0.44	0.22	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	5.91	8.27	1.58	1.18	0.79	0.39	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.82	12.36	2.32	2.32	2.32	0.77	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	17.01	8.01	0.00	2.00	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	5.32	3.73	1.06	0.80	0.53	0.13	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	5.32	4.88	1.77	1.55	0.44	0.44	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	6.02	3.46	1.41	0.77	1.28	0.26	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	4.23	5.54	1.95	1.95	0.33	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	3.84	5.61	1.48	1.48	0.59	0.30	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	3.56	2.99	0.71	0.71	0.28	0.43	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.69	6.02	1.95	1.14	0.65	0.33	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	4.87	5.18	0.61	0.61	0.30	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	11.62	8.08	1.26	1.52	2.02	0.51	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	18.36	0.00	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.01	8.58	0.95	1.91	2.86	0.95	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	3.39	5.16	1.33	0.44	1.03	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	5.38	4.09	3.01	0.43	1.08	0.22	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	5.25	4.30	1.36	0.84	1.05	0.42	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	6.65	5.88	1.55	1.08	0.62	0.46	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	8.62	3.23	1.08	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5.08	6.87	2.99	0.90	0.60	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.76	7.85	3.07	0.68	1.71	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	6.52	6.99	1.73	0.47	0.94	0.16	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	2.72	4.03	1.11	0.50	0.70	0.50	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	5.69	7.51	2.73	0.46	0.68	0.68	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.64	9.06	1.21	1.21	3.02	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	5.83	3.71	1.59	1.85	0.79	0.53	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	5.73	5.19	1.73	0.53	0.67	0.27	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	5.01	7.01	1.13	0.25	1.38	0.25	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.58	4.31	0.76	2.03	0.25	0.00	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	7.09	7.24	1.06	1.36	0.90	0.00	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	8.25	6.75	0.75	0.75	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	9.05	6.46	1.29	1.29	3.88	0.00	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	11.16	6.98	0.00	1.40	2.33	0.00	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	9.09	4.54	2.52	0.50	0.50	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.95	5.64	0.63	0.31	1.57	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.83	5.90	0.29	1.18	0.88	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	5.66	4.75	1.33	0.75	0.17	0.25	0.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	5.61	8.41	2.80	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.76	4.32	0.72	1.01	0.58	0.43	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	9.69	6.37	1.78	1.02	1.02	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.27	4.89	1.13	0.38	0.75	0.19	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	2.93	4.47	0.98	0.84	0.56	0.56	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	4.36	4.44	1.17	1.09	1.26	0.17	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.19	8.57	2.38	2.86	0.95	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	5.38	6.36	0.98	1.71	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	3.54	4.64	1.10	0.88	0.88	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	6.44	5.85	1.76	0.59	0.29	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	2.14	2.92	0.97	0.97	0.58	0.00	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	2.64	2.64	0.79	0.26	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	3.72	1.86	1.49	0.74	0.00	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	2.16	5.39	0.00	0.36	0.72	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	3.97	6.25	1.42	1.14	0.57	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	2.36	4.73	1.18	1.97	0.39	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	3.56	3.05	0.25	0.00	0.25	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	4.79	5.19	1.20	0.40	0.80	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	3.76	2.09	0.84	0.42	1.25	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	5.96	3.21	2.75	0.46	1.38	0.00	0.00
Synoviocyte, donor1	11291-117A4	4.38	4.88	0.67	0.34	0.17	0.34	0.50
Synoviocyte, donor2	11368-117I9	6.37	6.03	1.34	0.67	0.17	0.17	1.51
Synoviocyte, donor3	11440-118H9	2.23	6.03	1.34	0.45	0.89	0.00	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	3.93	7.86	1.07	2.14	1.07	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	21.80	0.00	1.98	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	7.64	6.02	2.55	1.62	1.39	1.16	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	8.75	6.02	1.94	1.08	1.65	0.29	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	24.74	7.73	1.93	1.16	5.41	0.00	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	18.90	8.59	4.01	1.72	1.15	0.00	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	6.77	7.38	2.46	1.23	2.34	0.86	0.86
Urethra, donor2	10319-105A4	0.00	8.99	1.80	0.00	1.80	1.80	1.80
Urothelial Cells, donor1	11520-119H8	5.84	2.92	1.86	1.33	0.80	0.27	0.27
Urothelial Cells, donor2	11600-120H7	8.41	3.61	1.20	1.20	2.00	0.40	0.80
Urothelial Cells, donor3	11681-122H7	5.50	6.42	2.52	2.06	2.29	0.23	0.23
Urothelial cells, donor0	11216-116B1	4.24	1.78	1.34	0.67	1.78	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	14.24	24.02	6.23	2.67	1.78	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	11.44	21.44	5.72	0.00	1.43	5.72	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	10.95	17.11	3.42	1.37	2.05	1.37	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	7.92	17.91	2.07	1.38	1.38	1.72	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	4.65	19.17	5.23	1.74	1.74	0.58	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	10.41	26.03	0.00	1.04	1.04	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	11.93	22.94	2.75	3.67	1.84	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	8.22	15.52	2.74	1.83	0.91	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	6.78	2.84	1.11	0.49	2.71	0.62	0.12
Wilms' tumor cell line:HFWT	10597-108E3	7.92	1.76	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	6.42	5.87	0.28	0.84	0.00	0.28	0.56
achilles tendon, donor2	10292-104G4	4.13	10.33	0.00	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	15.04	7.65	1.53	1.78	1.02	0.51	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	9.75	8.36	2.09	2.09	3.48	1.39	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	5.70	7.95	1.19	1.07	2.85	2.37	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	10.07	10.07	3.54	2.45	0.82	0.00	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	16.30	7.59	1.97	2.25	0.56	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	17.55	11.00	2.11	0.42	1.69	0.63	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	8.17	3.81	2.45	1.09	1.91	1.09	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	10.13	7.49	1.76	2.64	0.44	1.32	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	10.21	10.62	4.08	1.23	1.63	1.63	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	16.31	10.87	4.27	2.33	0.78	1.55	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	12.14	6.81	3.31	0.55	2.21	0.37	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	7.80	11.70	0.00	11.70	11.70	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	9.30	7.90	3.49	1.39	2.32	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	6.99	11.91	2.33	3.37	2.59	2.07	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	5.55	7.89	0.88	0.58	3.21	1.75	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	4.18	6.51	3.72	0.46	2.79	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	6.17	9.05	3.70	0.41	2.06	1.65	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	8.29	5.53	2.46	0.92	1.23	1.53	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	5.97	9.81	1.71	0.85	0.43	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	5.76	8.49	1.21	1.82	0.61	0.91	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	9.39	6.02	2.17	1.20	0.72	1.44	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	12.25	2.90	2.00	0.45	1.11	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	7.34	5.00	0.67	1.33	1.67	2.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1.86	7.43	1.86	1.86	3.72	9.29	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	14.31	11.68	3.77	1.88	1.88	3.01	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	4.80	1.74	1.31	0.87	2.62	3.05	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1.87	5.62	7.50	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	10.83	7.30	1.65	0.47	1.18	1.65	1.18
adipose tissue, adult, pool1	10010-101C1	3.26	8.22	1.09	0.78	1.40	0.93	1.09
adipose, donor1	10184-103D4	3.52	2.35	0.59	2.93	4.69	19.94	0.00
adipose, donor2	10185-103D5	2.03	4.06	0.41	1.22	2.43	6.08	0.00
adipose, donor3	10186-103D6	5.17	4.08	0.27	1.09	1.91	3.54	0.27
adipose, donor4	10187-103D7	6.07	2.60	0.87	0.87	4.33	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	12.31	4.58	0.95	2.37	1.26	1.42	0.16
adrenal gland, adult, pool1	10081-102A9	0.00	10.91	0.00	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	13.74	9.07	1.87	1.33	3.34	1.20	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	10.72	3.22	1.43	1.07	0.71	1.07	0.71
amniotic membrane cells, donor1	12235-129G3	3.94	3.71	1.62	1.39	0.93	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	3.04	4.73	2.03	0.68	0.00	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	2.06	3.83	1.47	1.18	0.00	0.88	0.29
amygdala - adult, donor10196	10167-103B5	9.49	1.19	3.56	3.56	3.56	3.56	0.00
amygdala, adult, donor10252	10151-102I7	5.88	5.88	1.82	3.85	3.04	2.23	0.81
amygdala, newborn, donor10223	10360-105E9	3.55	4.52	0.97	3.55	4.84	0.65	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	8.02	5.09	0.76	1.40	1.15	0.51	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	13.46	9.05	2.21	2.43	1.32	0.66	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	10.36	4.68	0.33	1.00	1.67	0.67	0.67
aorta, adult, pool1	10052-101G7	0.98	3.73	0.59	0.78	1.37	0.59	0.98
appendix, adult	10189-103D9	5.43	10.48	1.16	0.39	0.78	1.55	3.10
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	16.16	7.91	2.75	0.69	3.10	1.38	1.03
artery, adult	10190-103E1	2.72	4.08	0.00	0.00	1.36	4.08	0.00
astrocytoma cell line:TM-31	10425-106D2	6.23	8.40	1.45	3.04	2.17	2.32	0.43
b cell line:RPMI1788	10427-106D4	10.26	5.20	1.04	1.19	1.34	0.30	1.04
basal cell carcinoma cell line:TE 354.T	10702-109G9	3.05	6.10	1.66	1.94	0.28	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	7.64	7.14	0.99	1.49	0.50	1.19	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	5.69	7.20	0.84	0.33	0.33	1.00	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	15.66	8.95	2.24	0.56	3.36	1.12	1.12
bladder, adult, pool1	10011-101C2	4.13	5.32	0.54	0.43	0.65	0.54	0.33
blood, adult, pool1	10053-101G8	8.86	4.43	0.00	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	4.28	7.71	1.71	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	3.37	4.05	2.70	1.35	0.67	2.70	0.67
brain, adult, donor1	10084-102B3	11.28	9.23	0.00	3.08	2.05	4.10	1.03
brain, adult, pool1	10012-101C3	8.69	6.90	1.11	2.56	2.78	3.79	0.78
brain, fetal, pool1	10085-102B4	16.03	5.34	0.00	10.69	8.01	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	11.56	4.29	0.66	1.65	0.66	0.66	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	7.99	8.24	1.37	1.37	2.62	0.75	0.62
breast, adult, donor1	10080-102A8	0.63	4.42	0.00	0.63	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	6.86	8.38	2.16	0.25	0.38	0.76	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	3.09	3.09	1.86	0.00	0.31	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	8.29	4.14	1.38	5.30	1.84	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	2.18	0.97	0.00	0.24	0.24	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	7.99	6.58	0.94	0.94	8.46	3.29	0.47
carcinoid cell line:NCI-H727	10735-110B6	15.86	6.89	1.42	2.84	3.72	2.52	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	2.54	1.27	0.00	0.32	0.63	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	4.26	7.45	1.33	0.53	2.40	0.53	0.53
caudate nucleus - adult, donor10196	10177-103C6	3.45	3.45	3.45	0.00	0.00	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	5.35	6.86	0.84	2.01	1.34	3.18	0.84
caudate nucleus, adult, donor10258	10379-105H1	6.88	3.06	1.53	1.53	2.29	3.82	0.00
caudate nucleus, newborn, donor10223	10354-105E3	1.83	5.13	1.46	4.39	1.83	1.83	0.00
cerebellum - adult, donor10196	10173-103C2	2.91	2.91	0.00	0.00	14.57	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	4.48	7.47	1.07	1.07	8.75	1.49	0.43
cerebellum, adult, pool1	10083-102B2	4.83	6.21	0.69	0.69	6.55	2.07	0.34
cerebellum, newborn, donor10223	10357-105E6	4.98	6.64	0.83	3.32	3.32	1.66	0.83
cerebral meninges, adult	10188-103D8	9.58	6.56	0.50	1.01	1.51	5.04	0.25
cerebrospinal fluid, donor2	10294-104G6	3.65	2.19	0.00	1.46	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	10.78	5.90	0.72	1.87	2.16	1.58	0.86
cervical cancer cell line:ME-180	10553-107I4	8.12	6.30	0.83	1.33	0.50	0.99	0.50
cervix, adult, pool1	10013-101C4	4.41	6.19	0.94	0.84	1.15	0.84	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	10.59	11.98	4.04	1.53	2.23	0.98	1.25
chondrosarcoma cell line:SW 1353	10700-109G7	2.61	1.31	1.31	2.61	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	6.96	4.97	1.37	1.24	1.74	0.87	0.00
choriocarcinoma cell line:SCH	10785-110H2	3.45	4.31	0.49	0.62	1.23	0.37	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	3.08	2.37	0.47	0.47	0.95	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	3.42	3.99	1.71	1.42	0.85	0.57	0.57
chorionic membrane cells, donor2	12239-129G7	4.37	4.47	0.89	0.89	1.09	0.50	0.50
chorionic membrane cells, donor3	12240-129G8	2.20	5.49	0.00	0.55	1.10	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	9.09	8.08	3.03	1.01	1.01	1.01	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	7.11	6.15	2.31	0.77	0.58	0.19	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	6.97	9.50	1.48	0.42	1.27	1.06	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	3.08	2.57	1.03	0.77	3.34	2.82	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	2.42	2.42	0.97	2.90	1.69	2.90	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	3.66	1.43	1.22	0.61	2.04	1.43	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	7.66	7.95	2.65	2.65	1.47	2.65	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	9.12	8.08	0.78	1.04	1.04	2.09	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	5.03	4.34	1.14	2.51	0.91	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	7.29	4.34	0.35	1.39	1.56	1.21	0.00
colon carcinoma cell line:CACO-2	10513-107D9	10.62	7.32	1.46	1.46	0.92	1.10	0.18
colon carcinoma cell line:COLO-320	10420-106C6	4.94	3.80	0.00	1.90	2.28	1.14	0.00
colon, adult, donor1	10082-102B1	7.14	8.33	2.38	1.19	0.00	1.19	3.57
colon, adult, pool1	10014-101C5	7.64	13.28	2.47	1.88	1.65	2.12	0.82
colon, fetal, donor1	10070-101I7	1.85	4.33	0.62	0.62	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	64.17	41.25	4.58	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	8.50	14.02	2.12	0.85	0.85	1.27	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	5.74	5.13	1.51	0.45	0.91	0.15	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	5.22	4.94	1.41	1.97	2.12	0.42	0.00
corpus callosum, adult, pool1	10042-101F6	9.62	13.49	2.21	3.98	2.99	6.19	1.55
cruciate ligament, donor2	10295-104G7	2.43	4.05	0.00	0.81	0.81	0.00	1.62
diaphragm, fetal, donor1	10069-101I6	0.80	1.61	0.80	0.00	0.80	2.41	0.80
diencephalon, adult	10193-103E4	7.44	6.72	1.68	2.16	1.68	4.80	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	14.24	5.97	1.61	1.38	2.98	5.05	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	4.62	7.18	1.03	1.03	0.00	0.77	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	9.39	2.17	1.93	2.17	0.96	0.72	0.24
ductus deferens, adult	10196-103E7	2.99	5.48	2.99	1.50	2.99	2.49	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	1.44	10.08	0.00	0.00	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	3.68	8.83	2.21	5.15	1.47	2.21	1.47
dura mater, adult, donor1	10041-101F5	6.77	12.06	1.73	1.24	1.07	1.07	0.99
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	52.85	14.66	4.00	2.44	5.11	7.99	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	6.73	3.15	1.15	1.00	1.86	2.01	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	1.85	4.93	0.00	0.00	0.62	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	3.33	4.24	0.30	0.30	0.91	0.91	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	2.16	3.40	0.31	0.00	0.62	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	5.25	3.94	2.63	1.31	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	5.03	2.68	1.01	1.01	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	14.86	15.22	2.54	1.63	2.72	1.45	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	5.95	5.79	1.13	2.73	0.96	0.00	0.32
epidermoid carcinoma cell line:A431	10426-106D3	7.23	5.89	1.56	1.00	0.44	0.56	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	6.93	5.94	1.54	1.43	0.99	0.44	0.44
epididymis, adult	10197-103E8	4.81	6.70	2.09	0.21	1.67	2.30	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	4.44	6.74	1.24	1.06	0.53	1.06	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	4.72	4.33	1.97	0.39	0.39	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	12.19	6.81	2.10	1.44	2.49	1.44	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	12.79	5.41	1.08	1.38	2.76	1.57	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	10.42	10.08	1.57	0.90	3.25	2.35	0.67
esophagus, adult, pool1	10015-101C6	4.78	5.31	0.42	0.85	1.27	0.74	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	6.76	4.76	0.38	1.13	0.63	0.38	0.00
eye - muscle inferior rectus, donor1	10272-104E2	2.41	7.24	7.24	0.00	2.41	2.41	2.41
eye - muscle lateral, donor2	10298-104H1	0.00	2.10	0.00	0.00	2.10	2.10	0.00
eye - muscle medial, donor2	10299-104H2	7.44	5.95	0.00	0.00	2.98	7.44	1.49
eye - muscle superior, donor2	10297-104G9	2.29	1.15	1.15	1.15	0.00	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	0.00	2.91	0.00	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	4.07	3.81	0.51	1.27	2.54	2.80	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	11.41	5.77	1.28	1.80	0.51	0.38	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	13.77	10.45	3.56	2.85	1.42	0.95	1.42
frontal lobe, adult, pool1	10040-101F4	8.54	4.69	1.31	3.94	3.38	4.97	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	7.81	12.31	1.80	0.60	0.00	1.20	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	12.71	18.10	3.02	4.02	2.74	2.38	1.83
gall bladder, adult	10198-103E9	4.35	7.73	1.21	1.69	1.21	1.93	0.72
gamma delta positive T cells, donor1	11937-126A2	20.40	27.38	9.13	3.76	2.68	3.22	0.54
gamma delta positive T cells, donor2	11938-126A3	20.92	20.17	6.72	1.87	0.75	1.87	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	6.97	8.45	0.42	1.06	1.27	1.69	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	10.25	10.83	1.93	1.16	0.39	2.32	0.97
gastric cancer cell line:AZ521	10549-107H9	7.87	3.44	2.13	2.30	3.12	1.31	0.16
gastric cancer cell line:GSS	10560-108A2	9.15	7.32	0.92	3.66	10.07	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	5.48	3.43	1.37	2.06	0.91	2.06	0.00
giant cell carcinoma cell line:LU65	10487-107B1	2.18	1.84	1.03	0.11	0.46	0.34	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	3.64	4.48	1.12	1.12	0.98	0.42	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	4.49	5.99	0.75	0.50	0.75	1.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	6.23	4.75	1.90	0.42	0.74	0.42	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	5.34	6.46	0.84	0.14	0.56	0.70	0.28
glioblastoma cell line:T98G	10485-107A8	5.52	5.96	0.66	0.77	1.66	0.00	0.22
glioma cell line:GI-1	10413-106B8	4.69	3.22	0.00	0.29	0.88	1.46	0.29
globus pallidus - adult, donor10196	10175-103C4	6.56	2.92	1.46	2.92	5.10	2.92	0.00
globus pallidus, adult, donor10252	10161-103A8	7.32	12.20	1.71	2.93	3.42	4.39	1.95
globus pallidus, adult, donor10258	10367-105F7	2.74	2.74	2.74	0.00	1.37	5.48	1.37
globus pallidus, newborn, donor10223	10364-105F4	4.80	4.80	2.13	3.20	2.13	3.73	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	58.73	26.92	22.02	2.45	7.34	2.45	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	15.68	0.00	0.00	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	1.60	2.88	0.64	1.28	1.28	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	6.89	2.75	0.92	1.38	6.43	2.30	0.00
hIPS +CCl2, biol_rep2	14384-156C1	4.12	1.37	0.91	4.12	5.49	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	11.59	3.86	0.64	4.51	3.22	3.22	0.00
hIPS, biol_rep1	14380-156B6	10.06	4.31	1.44	1.44	5.75	1.44	0.00
hIPS, biol_rep2	14381-156B7	8.23	0.00	0.69	2.06	2.74	0.69	0.00
hIPS, biol_rep3	14382-156B8	5.52	5.52	1.10	1.10	3.31	4.41	0.00
hairy cell leukemia cell line:Mo	10712-109I1	10.92	7.18	2.01	0.29	3.45	0.57	0.57
heart - mitral valve, adult	10205-103F7	4.48	3.29	0.60	0.30	0.60	1.49	0.30
heart - pulmonic valve, adult	10206-103F8	1.31	2.35	1.31	0.52	0.52	1.83	0.52
heart - tricuspid valve, adult	10207-103F9	0.83	5.83	1.67	0.83	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	1.84	6.12	1.02	1.02	0.82	0.82	0.20
heart, adult, diseased, donor1	10051-101G6	2.13	8.52	1.28	1.70	0.43	1.28	0.43
heart, adult, pool1	10016-101C7	3.22	4.60	0.46	0.69	0.46	0.69	0.00
heart, fetal, pool1	10046-101G1	3.18	4.83	0.51	1.13	0.82	1.33	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	0.93	2.47	0.93	0.31	0.00	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	5.95	2.38	0.00	0.00	2.38	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	3.98	2.65	0.66	1.55	1.77	0.99	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	6.55	2.67	0.85	1.82	2.55	0.73	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	5.46	2.22	0.71	1.92	2.12	0.51	0.20
hepatoma cell line:Li-7	10484-107A7	4.56	3.67	1.67	0.78	0.56	1.33	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	12.96	5.53	1.31	0.70	2.01	1.41	0.70
hippocampus - adult, donor10196	10169-103B7	7.57	2.84	3.79	2.84	2.84	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	5.51	5.10	1.02	2.65	3.67	4.69	1.02
hippocampus, adult, donor10258	10374-105G5	3.49	1.99	0.00	2.99	1.00	5.48	0.50
hippocampus, newborn, donor10223	10363-105F3	7.75	2.82	2.47	1.41	3.88	1.06	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	14.04	2.44	1.83	4.27	7.32	2.44	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	7.07	3.14	1.77	4.32	5.69	0.98	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	5.08	2.03	0.76	3.05	5.33	2.54	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	4.51	0.56	1.69	1.13	14.66	2.82	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	6.46	1.81	0.52	2.58	11.36	5.94	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	6.83	1.14	2.28	2.28	15.94	7.97	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	6.13	2.34	0.88	2.04	7.88	6.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	7.97	4.52	1.94	1.51	6.46	4.31	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	2.50	3.34	0.42	0.42	10.43	6.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	4.74	3.32	1.18	2.84	3.32	4.03	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	3.70	2.09	1.29	2.25	4.34	3.54	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	8.75	5.39	1.35	5.39	3.37	4.71	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	8.92	1.41	0.31	2.35	4.23	2.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	5.40	1.97	0.00	0.98	2.95	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	5.24	1.75	0.00	3.49	2.62	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	5.35	1.72	0.76	0.76	6.68	9.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	3.49	0.87	0.44	0.87	7.41	9.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	6.00	1.00	1.50	1.00	6.50	7.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	4.90	4.14	0.94	1.13	1.51	6.41	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	6.37	5.00	1.36	0.45	3.64	6.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	3.76	6.26	0.94	1.25	4.07	7.83	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	3.43	2.78	1.31	0.98	1.96	4.90	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	4.06	2.90	1.74	1.74	1.16	4.35	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	4.78	2.69	1.49	2.39	2.09	6.88	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	8.68	2.59	0.92	3.14	7.21	0.92	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	9.13	2.85	0.00	1.71	6.56	1.14	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	11.84	4.49	0.00	4.08	6.12	1.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	5.63	3.17	0.70	2.82	7.39	4.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	5.70	2.85	2.85	1.90	5.07	2.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	5.75	1.51	1.21	3.03	10.89	3.93	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	7.76	4.14	1.55	1.03	5.17	5.17	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	3.32	3.32	1.99	1.99	3.32	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	4.36	4.62	1.03	2.82	5.39	1.80	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	4.09	5.11	1.28	3.07	2.56	1.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	4.54	6.06	0.76	3.03	3.79	3.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	6.05	4.03	1.01	1.68	4.03	2.69	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	9.90	2.90	0.72	3.86	9.90	1.21	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	9.36	4.01	0.89	4.90	7.13	1.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	8.78	2.93	0.98	3.41	8.29	1.46	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	3.67	2.75	0.92	2.44	6.72	3.97	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6.51	0.00	3.25	9.76	6.51	35.79	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	6.62	2.65	0.99	6.62	12.58	10.59	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	6.02	4.38	0.55	1.09	7.66	4.93	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	4.70	4.70	1.81	1.09	3.98	3.62	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	3.91	2.14	1.07	2.14	6.76	4.63	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	2.39	3.58	4.77	2.39	4.77	4.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	6.09	4.20	1.35	3.66	4.47	3.11	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	2.96	1.62	0.54	2.16	4.04	1.62	0.00
immature langerhans cells, donor1	11904-125F5	10.65	12.35	1.94	1.21	0.24	0.48	0.97
immature langerhans cells, donor2	11905-125F6	11.88	6.34	1.58	0.00	0.00	0.79	3.17
insula, adult, pool1	10039-101F3	9.84	7.48	2.27	4.73	3.50	4.35	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	9.10	7.48	1.30	0.65	2.28	0.33	0.00
kidney, adult, pool1	10017-101C8	6.51	6.81	1.80	1.50	0.90	1.90	1.00
kidney, fetal, pool1	10045-101F9	5.23	6.08	1.84	1.98	1.56	1.91	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	8.66	7.81	0.85	1.28	0.14	1.14	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	10.92	4.01	0.83	1.24	0.97	0.55	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	2.20	2.94	0.18	0.37	0.18	0.55	0.00
left atrium, adult, donor1	10079-102A7	1.09	4.90	0.00	0.00	2.72	2.18	0.00
left ventricle, adult, donor1	10078-102A6	2.02	4.05	1.01	0.51	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	5.75	1.64	0.82	0.55	0.27	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	4.67	8.98	0.72	1.08	0.72	0.00	1.80
leiomyoma cell line:15242A	10570-108B3	4.89	7.07	1.09	0.54	0.54	0.54	0.54
leiomyoma cell line:15425	10571-108B4	4.37	5.83	1.46	0.97	0.49	0.73	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	4.18	3.14	1.05	1.05	1.05	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	17.00	7.91	2.83	0.83	0.47	1.18	0.47
liposarcoma cell line:KMLS-1	10782-110G8	1.87	4.37	0.62	0.47	0.47	0.16	0.47
liposarcoma cell line:SW 872	10726-110A6	8.29	5.00	1.71	1.10	1.95	0.97	0.61
liver, adult, pool1	10018-101C9	11.99	11.99	2.27	0.97	0.65	0.81	1.30
liver, fetal, pool1	10086-102B5	3.76	4.70	1.88	0.94	0.94	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	4.81	2.77	1.60	1.02	1.60	2.77	0.73
locus coeruleus, adult, donor10252	10165-103B3	7.94	7.94	2.21	2.58	3.69	5.17	0.74
locus coeruleus, adult, donor10258	10375-105G6	7.34	11.00	1.97	2.82	1.13	3.39	0.56
locus coeruleus, newborn, donor10223	10362-105F2	1.68	4.63	0.42	0.84	0.00	1.26	0.00
lung adenocarcinoma cell line:A549	10499-107C4	6.09	6.78	0.97	1.66	0.42	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	11.03	3.45	0.00	1.38	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	3.56	3.82	0.53	0.26	0.79	0.40	0.40
lung, adult, pool1	10019-101D1	3.54	5.32	0.83	0.59	1.42	0.83	0.35
lung, fetal, donor1	10068-101I5	1.71	6.56	1.43	0.57	0.86	0.86	0.00
lung, right lower lobe, adult, donor1	10075-102A3	4.12	5.50	1.37	0.46	2.29	0.46	0.46
lymph node, adult, donor1	10077-102A5	10.41	7.57	0.47	0.00	0.95	1.42	0.00
lymphangiectasia cell line:DS-1	10727-110A7	13.59	5.70	1.97	1.75	0.88	3.51	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	6.19	6.64	1.06	1.36	1.36	1.81	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	2.55	8.49	1.70	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	4.44	15.98	1.78	0.00	0.44	1.78	1.33
mature adipocyte, donor2	12232-129F9	3.11	13.49	0.83	0.83	0.21	0.83	1.04
mature adipocyte, donor3	12233-129G1	2.61	12.33	1.42	1.19	1.66	0.24	1.42
mature adipocyte, donor4	12234-129G2	1.58	14.21	2.11	0.26	0.26	0.79	2.11
maxillary sinus tumor cell line:HSQ-89	10414-106B9	7.62	5.00	1.19	1.19	2.62	3.10	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	7.90	3.38	1.13	1.13	4.51	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	4.60	6.80	1.47	3.13	2.94	3.13	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	7.31	4.13	1.91	0.95	1.27	4.77	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	7.68	2.99	1.28	8.10	3.41	5.54	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	8.44	4.73	1.86	2.70	4.22	2.36	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	5.73	4.88	1.06	1.91	4.88	4.24	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	7.71	1.93	0.00	3.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	14.35	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	6.46	3.95	1.44	4.67	4.31	2.51	0.00
medulla oblongata - adult, donor10196	10174-103C3	4.54	7.79	0.00	1.30	0.65	1.95	0.65
medulla oblongata, adult, donor10252	10155-103A2	4.18	5.57	1.24	2.32	2.32	3.41	1.08
medulla oblongata, adult, pool1	10038-101F2	6.69	8.73	2.04	2.69	1.39	3.75	0.57
medulla oblongata, newborn, donor10223	10361-105F1	2.78	6.94	2.43	2.43	0.69	1.04	0.69
medulloblastoma cell line:D283 Med	10838-111E1	7.31	3.10	1.55	3.32	1.99	1.77	0.66
medulloblastoma cell line:ONS-76	10759-110E3	9.17	6.73	1.83	0.61	1.10	0.49	0.12
melanoma cell line:COLO 679	10514-107E1	4.46	4.74	0.29	1.29	0.72	0.86	0.57
melanoma cell line:G-361	10465-106H6	11.67	7.33	1.63	0.54	1.09	0.81	0.27
meningioma cell line:HKBMM	10691-109F7	8.32	4.52	0.72	1.45	0.36	0.36	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	6.17	8.81	0.88	3.52	7.05	3.52	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	12.70	8.81	3.89	2.33	5.96	4.93	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	6.90	4.30	1.53	0.92	0.46	0.31	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	4.00	3.82	0.55	0.73	1.09	0.36	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	3.31	4.97	2.90	0.00	1.24	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	4.78	2.11	0.42	0.00	0.56	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	5.01	4.24	0.39	0.19	0.77	0.19	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	4.16	3.47	1.39	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	2.40	5.32	0.69	1.20	1.72	0.17	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	3.80	5.18	1.04	0.35	0.92	0.00	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	4.91	4.38	2.25	0.80	0.66	0.13	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	4.46	3.38	1.35	0.81	0.27	0.41	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	3.56	1.99	0.57	0.43	0.43	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	1.32	3.62	0.66	0.33	0.99	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	3.60	3.74	0.55	0.55	0.83	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	3.84	5.24	1.05	0.70	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	2.45	3.27	1.02	2.04	1.02	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	2.52	4.67	0.72	1.44	0.72	1.44	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	2.07	2.48	0.41	0.83	0.72	0.21	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	2.96	2.51	0.91	0.46	0.46	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	5.87	5.03	0.84	1.26	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	4.33	4.48	0.90	0.60	0.45	0.30	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	2.89	3.06	0.70	0.44	1.05	0.35	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	2.21	3.31	1.10	0.00	0.74	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	5.72	4.01	1.14	0.86	0.00	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	3.79	3.79	0.84	1.68	0.00	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	4.11	4.57	1.83	1.37	0.91	0.46	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	4.35	5.88	1.02	1.53	0.00	0.00	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	5.24	7.85	2.36	1.31	0.26	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	3.39	5.24	0.62	0.31	0.62	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	3.06	8.00	0.47	0.94	0.47	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	5.75	4.06	2.37	1.02	0.68	0.34	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	4.32	3.93	1.18	0.79	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	4.63	6.49	1.39	1.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	7.79	9.81	2.60	1.44	0.58	0.00	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	6.02	6.92	1.78	0.67	0.67	0.22	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	4.33	7.45	2.16	1.20	1.20	0.72	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	3.67	2.93	0.73	0.73	0.00	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	3.69	4.03	2.69	0.67	0.00	0.34	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	3.68	6.14	2.46	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	3.87	4.73	1.72	0.00	0.86	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	8.20	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	7.47	5.85	0.65	0.65	0.32	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	0.00	1.45	0.00	2.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	6.40	6.93	1.07	0.00	1.60	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	5.72	8.18	1.64	0.82	2.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.44	8.16	1.55	0.39	1.55	0.39	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	6.30	0.00	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	6.95	10.93	4.97	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	4.74	5.93	2.96	0.59	0.59	1.19	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	8.53	7.31	1.22	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	7.60	2.53	1.27	1.27	1.27	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	8.97	3.45	2.41	0.69	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	2.15	2.15	0.00	4.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	3.99	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	0.00	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	7.74	4.48	1.22	0.41	3.26	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	8.74	2.38	2.38	0.79	3.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	11.79	11.20	1.18	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.17	4.36	1.56	0.62	1.25	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	6.68	2.67	2.67	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	13.01	7.10	2.37	0.00	1.18	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	10.27	2.57	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.01	13.77	3.44	0.69	1.38	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	9.90	11.38	4.45	0.99	1.48	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	8.97	8.97	2.24	2.24	2.24	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	7.63	10.81	2.54	0.00	3.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2.82	12.09	4.03	0.40	1.61	0.81	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	4.36	2.18	0.00	4.36	4.36	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	10.14	1.27	2.53	3.80	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	4.86	9.10	1.82	0.61	0.61	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	18.08	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	6.59	11.53	0.00	0.00	2.47	0.82	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	3.17	4.76	0.99	0.00	1.79	0.00	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	4.54	7.14	1.62	0.97	0.65	0.00	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	6.11	5.09	0.00	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	1.55	7.74	0.00	1.55	0.00	0.00	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	5.43	7.56	0.94	0.71	1.18	0.24	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	3.94	3.24	1.16	0.46	0.46	0.00	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	0.00	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	20.14	15.10	4.32	1.13	0.41	1.34	0.62
mesothelioma cell line:Mero-25	10850-111F4	6.35	6.81	1.13	1.36	0.00	0.45	0.45
mesothelioma cell line:Mero-41	10851-111F5	3.67	11.00	2.44	1.47	0.24	0.73	0.24
mesothelioma cell line:Mero-48a	10852-111F6	10.63	4.21	2.66	2.66	0.44	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	8.94	3.42	1.05	1.05	1.05	0.79	0.26
mesothelioma cell line:Mero-83	10854-111F8	5.11	3.40	1.36	1.19	0.34	0.34	0.17
mesothelioma cell line:Mero-84	10855-111F9	2.78	3.79	1.52	0.00	0.51	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	6.00	6.00	2.07	0.21	0.21	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	11.43	8.61	2.32	2.48	1.16	0.17	0.50
mesothelioma cell line:NCI-H226	10846-111E9	5.79	6.88	4.16	0.54	0.54	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	7.35	6.66	2.56	0.85	1.37	0.17	0.51
mesothelioma cell line:NCI-H28	10845-111E8	3.05	2.80	0.76	0.25	0.25	0.00	0.76
mesothelioma cell line:No36	10857-111G2	3.26	3.59	0.33	0.00	0.33	0.98	0.00
mesothelioma cell line:ONE58	10858-111G3	7.59	8.94	2.98	2.44	2.44	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	4.99	7.68	0.96	1.73	0.77	0.77	0.38
migratory langerhans cells, donor2	11902-125F3	5.25	10.62	1.47	1.22	2.20	1.10	0.24
migratory langerhans cells, donor3	11903-125F4	9.33	10.95	3.23	1.26	1.44	1.08	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	3.59	6.53	1.31	0.98	1.63	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	7.84	5.72	1.27	0.64	0.85	0.64	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	9.68	5.76	3.92	2.07	0.69	0.69	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	6.85	7.80	1.71	0.95	1.33	0.95	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	13.49	12.38	2.40	1.11	2.03	2.03	1.29
myeloma cell line:PCM6	10474-106I6	9.49	10.87	3.16	3.16	1.38	1.58	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	4.57	4.06	1.01	0.00	1.52	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	7.06	6.47	2.35	2.16	0.39	1.18	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	3.79	16.83	2.23	1.45	1.67	0.67	1.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	5.15	14.05	2.21	1.10	1.47	0.81	1.10
nasal epithelial cells, donor2	12227-129F4	8.28	9.38	0.00	2.21	0.00	0.00	1.66
neuroblastoma cell line:CHP-134	10508-107D4	10.58	6.21	1.15	1.15	2.76	4.37	0.23
neuroblastoma cell line:NB-1	10539-107G8	9.17	4.49	1.68	0.94	0.94	2.25	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	12.65	5.48	2.32	2.74	1.69	3.16	0.21
neuroblastoma cell line:NH-12	10555-107I6	9.13	2.24	1.49	1.86	2.24	5.22	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	6.64	2.14	1.42	3.32	1.42	2.37	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	2.69	3.01	1.27	2.06	1.27	1.90	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	4.03	4.83	0.60	1.61	1.01	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	5.09	2.54	0.00	1.27	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	3.73	3.99	1.33	0.27	0.53	0.27	0.53
neutrophil PMN, donor1	12133-128D9	74.37	89.25	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	13.28	0.00	26.56	0.00	0.00	13.28
neutrophil PMN, donor3	12141-128E8	28.41	9.47	0.00	9.47	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	6.43	8.29	0.85	0.85	0.85	0.85	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	8.01	6.40	2.40	3.20	1.60	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	4.49	3.85	0.32	0.64	0.00	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	4.73	4.99	1.84	0.79	1.05	0.53	0.53
nucleus accumbens, adult, pool1	10037-101F1	8.91	7.78	1.03	3.47	2.53	5.16	0.28
occipital cortex - adult, donor10196	10172-103C1	4.12	6.18	4.12	0.00	4.12	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	5.90	8.05	0.81	2.68	6.17	4.56	0.54
occipital cortex, newborn, donor10223	10355-105E4	10.19	5.82	1.09	5.46	5.82	5.10	0.00
occipital lobe, adult, donor1	10076-102A4	7.87	2.62	1.31	1.84	4.99	2.62	0.26
occipital lobe, fetal, donor1	10073-102A1	7.29	3.86	1.72	1.29	5.58	0.00	0.86
occipital pole, adult, pool1	10036-101E9	10.64	8.04	1.81	3.63	4.34	6.78	0.39
olfactory region, adult	10195-103E6	5.92	3.82	0.38	1.53	3.06	4.59	0.57
optic nerve, donor1	10277-104E7	10.01	4.00	2.00	4.00	10.01	6.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	4.44	3.99	1.25	1.14	0.91	0.91	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	7.01	9.07	1.65	2.34	1.10	0.27	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	7.96	5.93	2.54	1.19	0.85	1.19	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	4.62	1.85	1.04	0.81	0.46	0.12	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	5.59	4.12	1.76	0.88	1.76	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	6.54	5.61	0.93	1.87	0.00	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	2.12	3.82	0.21	0.85	0.64	0.85	0.00
ovary, adult, pool1	10020-101D2	4.02	4.54	0.79	0.35	0.52	1.05	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	6.23	4.77	2.02	0.18	0.55	0.55	0.37
pancreas, adult, donor1	10049-101G4	11.29	13.17	0.94	1.88	0.94	3.76	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	3.07	2.52	0.84	0.84	2.80	1.68	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	8.01	6.98	1.36	1.36	1.19	1.19	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	5.13	2.48	0.83	1.66	0.33	1.32	0.33
paracentral gyrus, adult, pool1	10035-101E8	8.69	6.68	1.37	2.47	2.11	3.75	0.55
parietal cortex, adult, donor10258	10373-105G4	7.34	7.34	0.73	2.94	0.00	2.20	0.73
parietal lobe - adult, donor10196	10171-103B9	3.76	4.70	1.88	0.00	3.76	5.64	0.94
parietal lobe, adult, donor10252	10157-103A4	6.56	3.71	1.71	2.28	4.85	1.71	0.57
parietal lobe, adult, pool1	10034-101E7	10.05	7.58	2.03	3.44	2.64	5.20	0.62
parietal lobe, fetal, donor1	10072-101I9	6.79	4.85	0.00	0.97	4.85	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	5.98	2.24	1.50	6.36	1.50	2.62	1.12
parotid gland, adult	10199-103F1	6.17	8.02	0.00	1.23	3.08	3.70	0.00
penis, adult	10200-103F2	3.76	4.83	0.54	0.00	0.54	1.61	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	7.81	4.46	0.74	1.49	2.23	1.30	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	7.43	11.51	1.89	1.31	0.44	0.73	0.73
pineal gland - adult, donor10196	10179-103C8	1.29	1.94	0.65	0.65	0.65	10.32	0.00
pineal gland, adult, donor10252	10160-103A7	3.55	2.37	0.59	1.18	2.37	10.66	1.18
pineal gland, adult, donor10258	10377-105G8	3.76	2.51	1.25	2.51	0.63	6.27	0.00
pituitary gland - adult, donor10196	10180-103C9	8.09	5.06	2.02	0.00	6.07	3.04	0.00
pituitary gland, adult, donor10252	10162-103A9	8.34	5.73	1.04	4.69	8.34	7.30	0.52
pituitary gland, adult, donor10258	10378-105G9	5.96	5.96	5.96	0.85	5.11	5.11	0.00
placenta, adult, pool1	10021-101D3	1.94	5.59	1.18	1.29	1.51	1.72	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	12.71	6.62	1.85	0.13	3.05	0.66	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	1.87	2.18	0.47	1.09	0.00	0.31	0.31
pons, adult, pool1	10033-101E6	6.89	6.63	1.55	2.15	1.46	3.36	0.52
postcentral gyrus, adult, pool1	10032-101E5	12.55	7.67	1.74	4.36	3.92	7.32	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	56.47	29.28	2.09	2.09	0.00	2.09	6.27
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	11.02	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	0.58	1.75	0.15	0.15	0.44	0.15	0.00
prostate cancer cell line:PC-3	10439-106E7	6.53	6.53	2.00	1.09	1.09	0.54	0.18
prostate, adult, pool1	10022-101D4	4.44	6.80	1.18	0.63	1.00	0.91	0.73
putamen, adult, donor10196	10176-103C5	10.15	5.43	1.42	5.19	0.71	4.49	0.94
putamen, adult, donor10252	10152-102I8	5.88	13.73	5.88	3.92	3.92	5.88	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	5.46	2.19	2.19	4.37	1.09	4.37	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	7.01	4.83	1.69	3.38	0.97	4.11	0.97
putamen, newborn, donor10223	10365-105F5	2.25	3.75	0.00	3.00	0.75	3.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	4.65	2.33	2.33	1.16	0.29	0.58	0.29
rectum, fetal, donor1	10067-101I4	2.78	0.00	0.00	0.00	0.00	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	3.39	5.94	1.06	1.06	1.91	0.85	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	4.97	4.14	1.66	0.41	0.00	1.24	0.00
retina, adult, pool1	10030-101E3	4.57	9.54	0.99	1.29	3.18	2.78	0.60
retinoblastoma cell line:Y79	10475-106I7	8.05	2.34	0.52	0.78	4.94	1.04	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	5.41	1.35	1.11	0.37	1.48	0.49	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	4.50	4.22	2.25	1.12	0.56	1.97	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	7.58	3.79	1.52	1.52	0.00	0.00	2.27
salivary acinar cells, donor1	11771-123I7	9.55	2.91	1.13	0.16	0.49	0.49	0.16
salivary acinar cells, donor2	11772-123I8	5.78	5.78	1.24	0.28	1.93	0.14	0.69
salivary acinar cells, donor3	11773-123I9	3.97	3.97	0.00	0.66	0.66	0.00	1.32
salivary gland, adult, pool1	10093-102C3	6.86	5.15	1.14	2.86	6.86	1.72	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	4.81	9.53	1.26	0.76	0.59	0.42	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	6.47	8.35	1.53	0.35	1.18	1.06	0.35
seminal vesicle, adult	10201-103F3	6.35	13.76	1.59	1.59	1.59	1.06	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	7.29	7.04	1.70	2.19	1.46	0.73	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	2.77	5.03	1.51	1.76	0.50	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	4.01	7.02	3.01	1.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	9.94	4.03	1.61	3.49	1.21	1.21	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	6.08	8.73	0.99	1.33	0.22	2.10	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	18.06	10.97	2.71	0.90	1.29	0.39	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	2.84	4.26	0.71	1.42	0.71	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	3.84	4.68	0.72	0.60	0.72	0.48	0.36
skeletal muscle, fetal, donor1	10066-101I3	3.02	1.01	0.00	0.00	0.00	2.01	0.00
skin, adult, donor1	10074-102A2	0.00	6.79	0.00	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	0.63	5.05	0.00	0.63	3.16	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	4.00	3.67	0.67	0.67	4.00	1.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	6.93	4.41	0.32	0.95	6.30	3.15	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	7.71	11.56	2.31	5.98	4.05	1.93	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	2.80	3.96	0.82	0.33	0.49	0.82	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	1.29	0.97	0.16	1.45	2.41	2.73	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	11.11	4.14	2.18	1.31	4.14	4.36	0.22
small intestine, adult, pool1	10024-101D6	7.41	14.69	2.27	5.49	0.96	2.87	1.55
small intestine, fetal, donor1	10064-101I1	5.65	5.41	1.23	0.98	0.74	0.74	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	8.72	8.21	1.03	2.05	2.56	2.56	0.51
smooth muscle, adult, pool1	10048-101G3	3.62	2.84	1.03	0.78	1.03	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	8.04	4.56	2.68	1.61	0.54	0.80	0.00
spinal cord - adult, donor10196	10181-103D1	5.74	5.05	1.61	1.15	2.29	3.21	0.69
spinal cord, adult, donor10252	10159-103A6	3.94	3.15	1.58	2.76	3.55	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	4.15	4.15	0.69	1.38	1.38	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	3.05	10.98	1.83	1.83	4.27	4.88	0.61
spinal cord, newborn, donor10223	10359-105E8	6.43	7.81	0.92	3.21	0.92	5.51	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	2.54	2.99	0.90	0.45	0.45	0.30	0.45
spleen, adult, pool1	10025-101D7	5.18	5.07	0.55	1.32	1.21	1.32	0.66
spleen, fetal, pool1	10044-101F8	5.56	7.79	1.11	1.59	0.64	1.03	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	11.70	9.01	2.17	1.14	1.86	0.31	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	15.76	20.13	3.99	2.28	1.14	1.71	2.09
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	3.84	4.19	0.70	1.40	1.05	2.45	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	30.49	18.76	5.08	2.74	1.95	5.08	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	22.85	27.80	3.26	2.70	2.03	3.15	1.69
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	4.24	3.39	2.97	1.27	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	0.00	1.69	0.00	1.27	1.69	0.42	0.42
stomach, fetal, donor1	10062-101H8	8.54	9.61	1.07	0.00	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	5.70	6.84	0.00	0.57	4.56	3.99	1.71
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	6.23	8.72	1.45	3.53	3.12	2.91	2.08
substantia nigra, adult, donor10258	10371-105G2	5.17	5.17	1.55	1.55	3.10	5.17	0.52
substantia nigra, newborn, donor10223	10358-105E7	1.41	3.53	0.71	3.53	1.41	2.12	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	2.75	2.52	1.83	0.69	0.92	1.60	0.00
temporal lobe, adult, pool1	10031-101E4	12.89	9.66	2.54	3.81	3.56	6.36	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	8.55	4.27	0.71	3.56	5.70	3.56	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	8.79	4.83	1.32	5.27	4.40	3.08	0.44
tenocyte, donor1	11763-123H8	2.44	4.54	0.70	0.35	0.35	0.00	1.05
tenocyte, donor2	11765-123I1	4.58	7.25	1.14	1.14	1.53	0.38	1.14
tenocyte, donor3	11768-123I4	1.11	4.45	1.85	0.74	1.11	0.74	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	10.71	3.57	2.04	1.36	4.25	1.19	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	5.24	2.16	1.08	0.92	1.08	2.16	0.00
teratocarcinoma cell line:PA-1	10807-111A6	5.58	0.93	0.93	1.70	0.62	2.94	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	6.60	2.54	2.03	1.78	0.63	0.13	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	6.81	1.13	0.00	1.51	0.76	1.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	7.74	2.51	1.53	1.53	0.87	0.76	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	9.45	4.89	1.95	2.28	1.95	3.91	0.00
testis, adult, pool1	10026-101D8	3.87	5.80	1.29	1.50	1.07	10.63	0.32
testis, adult, pool2	10096-102C6	0.90	5.86	0.45	1.35	0.90	27.52	0.00
thalamus - adult, donor10196	10168-103B6	5.52	5.52	3.31	2.21	1.10	3.31	0.00
thalamus, adult, donor10252	10154-103A1	4.53	8.13	1.41	0.94	2.34	2.81	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	4.62	12.32	1.54	7.70	4.62	4.62	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	5.11	6.42	1.81	0.99	1.81	1.65	0.82
thalamus, newborn, donor10223	10366-105F6	4.60	1.15	0.58	1.73	0.58	1.15	0.00
throat, adult	10209-103G2	3.00	5.49	1.00	0.25	1.75	0.75	0.25
throat, fetal, donor1	10061-101H7	2.44	4.27	0.61	0.61	0.30	1.22	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	8.94	3.18	1.19	2.78	4.77	0.60	0.40
thymus, adult, pool1	10027-101D9	7.85	10.34	2.29	1.79	1.09	2.49	0.60
thymus, fetal, pool1	10043-101F7	7.27	10.70	2.29	1.97	1.45	1.56	0.83
thyroid carcinoma cell line:KHM-5M	10776-110G2	7.84	6.52	1.46	0.66	2.79	0.93	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	9.78	8.66	1.82	1.12	0.70	0.56	1.54
thyroid, adult, pool1	10028-101E1	5.41	12.22	1.21	0.56	1.49	1.21	1.31
thyroid, fetal, donor1	10060-101H6	2.11	8.96	1.32	1.05	1.05	2.90	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	15.40	3.08	0.00	3.08	0.00	3.08
tongue, adult	10203-103F5	3.26	4.42	1.63	0.93	1.40	2.33	0.93
tongue, fetal, donor1	10059-101H5	1.97	2.76	0.00	0.00	0.79	1.97	0.00
tonsil, adult, pool1	10047-101G2	9.62	11.52	2.50	1.40	2.60	1.90	0.70
trachea, adult, pool1	10029-101E2	3.76	7.77	1.39	1.55	1.15	0.82	0.49
trachea, fetal, donor1	10058-101H4	1.92	5.39	1.92	0.77	1.15	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	3.90	2.48	1.42	0.35	0.71	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	4.86	4.36	1.32	0.61	2.33	0.71	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	4.86	5.33	0.63	0.94	0.31	1.25	0.31
tridermal teratoma cell line:HGRT	10694-109G1	7.61	5.71	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	6.01	4.57	1.02	1.02	0.08	0.68	0.25
umbilical cord, fetal, donor1	10057-101H3	2.09	4.17	0.00	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	4.61	7.68	1.37	1.19	0.68	0.68	1.37
uterus, fetal, donor1	10055-101H1	3.58	1.54	0.00	0.00	1.54	0.51	0.51
vagina, adult	10204-103F6	3.23	5.82	0.65	0.65	0.65	0.65	0.65
vein, adult	10191-103E2	5.70	8.11	2.19	1.32	0.22	1.53	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	10.15	6.14	1.60	0.80	0.27	0.53	0.53